Gefitinib (ZD1839)

Catalog No.S1025

Gefitinib (ZD1839) Chemical Structure

Molecular Weight(MW): 446.90

Gefitinib (ZD-1839) is an EGFR inhibitor for Tyr1173, Tyr992, Tyr1173 and Tyr992 in the NR6wtEGFR and NR6W cells with IC50 of 37 nM, 37nM, 26 nM and 57 nM, respectively.

Size Price Stock Quantity  
In DMSO USD 191 In stock
USD 147 In stock
USD 270 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Cited by 91 Publications

12 Customer Reviews

  • Perturbation of EGFR by its ligand EGF and gefitinib (ZD-1839 Iressat; inhibits EGFR) produces opposite responses in the predicted EGFR target genes SOCS2 and NR2E1.

    Mol Syst Biol 2011 7, 486. Gefitinib (ZD1839) purchased from Selleck.

    Effects of shRNA-mediated RECK depletion on EGFR signaling in MEFs. (a) Immunoblotting (IB) of the indicated proteins in wild-type MEFs transduced with the indicated shRNAs and cultured for 48 h in the presence of 0.1% dimethyl sulfoxide (DMSO; vehicle) or 1 mM gefitinib (S1025, Selleck Chemicals,Houston, TX, USA). (b) Immunoprecipitation from whole lysates of cells from panel a with an anti-phosphorylated tyrosine (pTyr) antibody. Precipitates from 500 mg protein in whole cell lysates (upper) or 20 mg protein in whole cell lysates (lower) were analyzed by IB with anti-EGFR antibody.

    Oncogene 2010 30, 737-750. Gefitinib (ZD1839) purchased from Selleck.

  • (B–C) LNCaP (B) and LNCaP-AI (C) cells were transiently transfected with sPLA2-IIa(-800)-Luc (0.5 μg). The cells were then treated with Erlotinib (20 μM), Gefitinib (20 μM), Lapatinib (20 μM), CI-1033 (8 μM), LY294002 (20 lM) and Bortezomib (20 μM) without or with EGF (100 ng/ml) for 24 h. Luciferase assay was performed according to a standard protocol with Renilla luciferase as an internal control. Data are presented as the mean (±SD) of duplicate values of a representative experiment that was independently repeated for five times.

    Carcinogenesis 2010 31, 1948–1955 . Gefitinib (ZD1839) purchased from Selleck.

    LNCaP-AI cells were starved in 1% stripped medium for 24 h. The cells were then treated with Erlotinib (20 μM), Gefitinib (20 μM), Lapatinib (20 μM), CI-1033 (8 μM), LY294002 (20 μM) and Bortezomib (20 μM) for 24 h. Cell culture medium was collected from each sample and subjected to ELISA for sPLA2-IIa. The condition medium samples were diluted 10 times for ELISA. Average of duplicate samples was converted to nanogram per milliliter against standard curve. The data represent one of five repeated experiments.

     

     

    Carcinogenesis 2010 31, 1948–1955. Gefitinib (ZD1839) purchased from Selleck.

  • Susceptibility of lung cancer cells to cytolytic activity of NK-92 cells after treatment with EGFR inhibitors. Three lung cancer cells were untreated (open circle) or treated with 10 μM erlotinib or gefitinib (black filled square or black filled triangle) for 24 hours. The lung cancer cells were cocultured with NK-92 cells at indicated effector to target ratio (E:T ratio). To determine the specificity of NKG2D-mediated cytolysis of lung cancer cells, NK-92 cells were preincubated with blocking mAb against NKG2D before the assay (gray filled square and triangle) and correspond-ing isotype mAb (open square and triangle).

    J Immunother 2011 34(4), 372-81. Gefitinib (ZD1839) purchased from Selleck.

    Suppression of EGFR signaling by Gefitinib is dose dependent and non- toxic at millimolar concentrations.Results from plaque reduction tests of Hep2 cells infected with VACV(12.5pfu/well) treated with a serial dilution of Gefitinib (1000-0.01 m) and analyzed for (A)proliferation as indicator of cytotoxicity,(B) IC50 of plaque size inhibition, (C)dose dependent inhibition of EGFR-ERK1/2signaling and VACV proteins by Western blot analysis (pEGFR detection was obtained from a different experiment with identicals ettings) and (D)dose dependent inhibition of orthopoxvirus genome replication by real-time PCR.Untreated VACV infectedcells and uninfected cells are shown as controls in the right panel.

    Antiviral Res 2010 89, 64-70. Gefitinib (ZD1839) purchased from Selleck.

  • A circular zone of EGFR activated but uninfected cells facilitate virus induced plaque development , efficiently blocked by Gefitinib. (A)Immun of luorescent staining of aplaque reduction tests with Hep2 cells 24,48,72 and 96 h after VACV infection (6.25pfu/chamber). VACV infected cells(green) were visualized by human IgG directed to orthopoxviruses (VIG) detected with a secondary FITC labelled antibody. Uninfected cells with activated EGFR signaling(red) are detected with a secondary Cy3labelled antibody. Positive cells for both , VACV and phosphorylated EGFR are shown in yellow(merge). Cellular nuclei are counterstained with DAPI. (B)Immunofluorescent staining of a plaque reduction test as described for (A) and treated with three different Gefitinib concentrations (1000 nM, 1 nM, and 0.01 nM) . The test was analyzed 96h afterVACV infection.Uninfected cells are shown as controls. Magnification100×.(For interpretation of the references to color in this figure legend , the reader is referred to the web version of the article.)

     

     

    Antiviral Res 2010 89, 64-70. Gefitinib (ZD1839) purchased from Selleck.

    The EGF-dependent increased association of PCM1 and AZI1 requires EGFR kinase activity. ZD1839 (Iressa)—EGFR tyrosine kinase inhibitor.

    Mol Biosyst 2011 7, 3223-33. Gefitinib (ZD1839) purchased from Selleck.

  • Reduction of GPER expression in HCC1806 cells after treatment with gefitinib. (A) Concentration dependence. HCC1806 cells were treated with 50-500 nM gefitinib for 48 h. GPER was detected by western blotting. (B) Time dependence. HCC1806 cells were treated with 200 nM gefitinib for 24-96 h. ap<0.05 vs. control; bp<0.001 vs. control. Mean values and SE of three independent experiments are shown. (C) Representative western blotting of concentration dependence. (D) Representative western blotting of time dependence

    Oncol Rep, 2017, 37(2):1212-1218. Gefitinib (ZD1839) purchased from Selleck.

    Inhibition of signaling pathway activation in lung tumor cell lines by kinase inhibitors. Lung tumor cells were cultured in 10% FBS until reaching ∼80% confluence and then the cells were starved in serum-free medium for overnight, followed by 4-hour treatment with the inhibitors. Cell lysates were then prepared and used for determination of the pathway activation signals by the CEER assay.

    Int J Proteomics 2011 215496. Gefitinib (ZD1839) purchased from Selleck.

  • Breast cancer cells were pretreated with 100ng/ml EGF for 15 min and then treated with the indicated concentrations of  Gefitinib for 24 hours.

     

     

    2010 Dr. Zhang of Tianjin Medical University. Gefitinib (ZD1839) purchased from Selleck.

    MTT assay result. 0-500nM Gefitinib treated with H1299, H358, H25 and HCC827 cell lines by 72h, Proliferation rate was tested.

     

     

    2010 Dr. Vicky Tin from University of Hong Kong. Gefitinib (ZD1839) purchased from Selleck.

Purity & Quality Control

Choose Selective EGFR Inhibitors

Biological Activity

Description Gefitinib (ZD-1839) is an EGFR inhibitor for Tyr1173, Tyr992, Tyr1173 and Tyr992 in the NR6wtEGFR and NR6W cells with IC50 of 37 nM, 37nM, 26 nM and 57 nM, respectively.
Features A potent EGFR tyrosine kinase inhibitor.
Targets
Tyr1173 (NR6W cells) [1] Tyr1173 (NR6wtEGFR cells) [1] Tyr992 (NR6wtEGFR cells) [1] Tyr992 (NR6W cells) [1]
26 nM 37 nM 37 nM 57 nM
In vitro

Gefitinib effectively inhibits all tyrosine phosphorylation sites on EGFR in both the high and low-EGFR-expressing cell lines including NR6, NR6M and NR6W cell lines. The phosphorylation sites Tyr1173 and Tyr992 are less sensitive requiring higher concentrations of Gefitinib for inhibition. Gefitinib effectively blocks the phosphorylation of PLC-γ, with IC50 of 27nM, in NR6W cells. The NR6wtEGFR and NR6M cell lines has low levels of PLC-γ phosphorylation but the level in the NR6M cell line is more resistant to inhibition by Gefitinib with IC50 of 43 nM and 369 nM, respectively. Gefitinib inhibits Akt phosphorylations, with IC50 of 220 and 263nM, in the low-EGFR- and -EGFRvIII-expressing cell lines, respectively. Gefitinib in the dose range from 0.1 to 0.5μM significantly facilitates, rather than abrogates, colony formation of NR6M cells. However, at a concentration of 2 μM Gefitinib completely blocks NR6M colony formation. Gefitinib rapidly and in a dose-dependent manner inhibits EGFR and ERK phosphorylation up to 72 hours after EGF stimulation in both the high- and low-EGFR-expressing cell lines. [1] Gefitinib is the monolayer growth of these EGF-driven untransformed MCF10A cells with an IC50 of 20 nM. [2] The combination of Gefitinib (0.2 μM and 0.5 μM) with irradiation lead to a significant growth inhibition in LoVo cells, compared with radiation alone.. [3]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
KB NF3VZ|lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYLJR|UxRTBwMEW0JO69VQ>? NYTBR457OTZ3MU[0O|M>
NIH3T3 Ml\uSpVv[3Srb36gRZN{[Xl? M1;I[FAvOiEQvF2= NFjDPYQzKGh? NX\t[W9STE2VTx?= M3P1SGlvcGmkaYTpc44hd2ZiRVfGJJN1cW23bHH0[YQhcHWvYX6g[ZJjSjFiYYX0c5Bpd3OyaH;yfYxifGmxbjD3bZRpKEmFNUCgc4YhOC5yMUS0JO69VQ>? MX[xOlQ5ODJ6NB?=
COS7 MVzGeY5kfGmxbjDBd5NigQ>? MYe5OkDPxE1? MUjJcohq[mm2aX;uJI9nKGi3bXHuJGpCUzJiVk[xO2YhdXW2YX70JIV5eHKnc4Pl[C=> NUHSRXNKOTdzN{i3NlI>
A549 NVq2R5JFS3m2b4TvfIlkKEG|c3H5 NH\RbZQ6PiCq NXHTWHNpTE2VTx?= M3fzSGlEPTB;MUOuOVkh|ryP NY\UNppQOTh|MUO4NFc>
K562 MXjDfZRwfG:6aXOgRZN{[Xl? MmfpPVYhcA>? NVHCXnZwTE2VTx?= MYDJR|UxRTlwM{[g{txO M2T4dVE5OzF|OEC3
MDA-MB-231 NVz0T5Z3S3m2b4TvfIlkKEG|c3H5 M{jaXFk3KGh? MoTzSG1UVw>? MmDBTWM2OD1|Nj62NUDPxE1? MUmxPFMyOzhyNx?=
MOLT4 NULRVoNQS3m2b4TvfIlkKEG|c3H5 MXu5OkBp MYfEUXNQ M2exfmlEPTB;MUWuNFIh|ryP NXPhU3FoOTh|MUO4NFc>
MCF7 M{LXdWN6fG:2b4jpZ{BCe3OjeR?= NFjQT4g2OCEQvF2= NWXQcmdOPzJiaB?= NXq2NoE5UUN3ME2xNk4xPSEQvF2= NF6zR3YyQDd5MUixPS=>
BT474 NVTjUmQ2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1TEdlczKGh? NVX0VnFZSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDCWFQ4PCClZXzsd{BwfmW{ZYjwdoV{e2mwZzDFVmJjOiC5aYToJGVEPTBib3[gNE4{KM7:TR?= MVixPVAzQDR{NB?=
HN5 MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NIDRZXA4OiCq M4rZeGFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iSF61JINmdGy|IH;2[ZJmgHC{ZYPzbY5oKEWJRmKge4l1cCCHQ{WwJI9nKDBwMEGg{txO Mom3NVkxOjh2MkS=
BA/F3 NH:3N5pEgXSxdH;4bYMhSXO|YYm= NHuweJk4OiCq MXHDfZRwfG:6aXPpeJkh[WejaX7zeEBud3W|ZTDCRU9HOyClZXzsd{BmgHC{ZYPzbY5oKEWJRmKgUFg2QFJibYX0ZY51KHerdHigTWM2OCCxZjCwMlAyODhizszN M{LIbFE6OjN7MkK5
NIH3T3 NXvuTmt5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MoS3O|IhcA>? NYL4WI4{T3Kxd4ToJIlvcGmkaYTpc44hd2ZibX;1d4UhVkmKL{PUN{Bk\WyuczDlfJBz\XO|aX7nJIVzSjJiZ3Xu[UB4cXSqIFnDOVAhd2ZiMD61OEDPxE1? NEn4PXkyQTZ4NUO3Oy=>
MCF7 MX MU\GeY5kfGmxbjDBd5NigQ>? NULkXFNbOzBibXnu MUjJcohq[mm2aX;uJI9nKEKFUmCg[ZhxemW|c3XkJJdqfGhiSVO1NEBw\iBzLkGg{txO NIfveW4yQTl|Mkm2NC=>
A431 NEe1SXBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{O0NlExKM7:TR?= MkDZO|IhcA>? NXzZNmw3T0l3ME2wMlUyPCEQvF2= MVqxPVk3QTR4NR?=
A431 M3;OWmtqdmG|ZTDBd5NigQ>? NF7rVG8xNjFizszN MVmxJIg> M2Lh[GlvcGmkaYTpc44hd2ZiRVfGMYlv\HWlZXSgSWdHWiCyaH;zdIhwenmuYYTpc44> MkixNVk6Pjl2NkW=
A431 M3jKdGtqdmG|ZTDBd5NigQ>? NV7HeIRLOTByIN88US=> MX2xNEBucW5? NW\JOW5GWHKxbH;u[4VlKGmwaHnibZRwenliYXP0bZZqfHlib3[gSWdHNWmwZIXj[YQhTUeIUjDwbI9{eGixconsZZRqd25? MlnsNVk6Pjl2NkW=
Sf9 Ml\PT4lv[XOnIFHzd4F6 MnH4NVAhdWmw MljrSG1UVw>? NVP3eXVSUW6qaXLpeIlwdiCxZjDFS2ZTKGW6cILld5Nm\CCjc4Pld5Nm\CCjczDpcohq[mm2aX;uJI9nKHKnY3XweI9zKGG3dH;wbI9{eGixconsZZRqd25id3n0bEBKSzVyIH;mJFAvODN|IN88US=> NUPDNnY1OjByNU[0NlU>
NCI-H1975 Ml3ES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXK1JO69VQ>? M17xfFczKGh? MUDJR|UxRThwMk[g{txO NICwTZkzODF3MU[3NC=>
NCI-H1975 MkXGT4lv[XOnIFHzd4F6 M4HKUFExKM7:TR?= NG\URoFKdmirYnn0bY9vKG:oIFXHSnIh[XW2b4Doc5NxcG:{eXzheIlwdg>? NEf5fGYzODF3MU[3NC=>
NCI-H1975 MY\GeY5kfGmxbjDBd5NigQ>? MV:xNEDPxE1? Mki2TY5pcWKrdHnvckBw\iCHUlLCNkBifXSxcHjvd5Bpd3K7bHH0bY9v NIO4NnozODF3MU[3NC=>
NCI-H1975 M2\uSWZ2dmO2aX;uJGF{e2G7 M{D3[VUh|ryP MoS3OFghcA>? MYLJcoR2[3Srb36gc4Yh[XCxcITvd4l{KGG|c3Xzd4VlKGG|IHHjeIl3[XSrb36gc4Yh[2G|cHHz[U0{ M2\EOFIxOTVzNkew
A375 NH7ORnVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlntOFghcA>? M2TtZmlEPTB;MkCuOVUh|ryP MXmyNFMxPDV|Nx?=
SMMC7721 M{Phb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVS0PEBp M3PvVWlEPTB;M{OuNVIh|ryP M13kfVIxOzB2NUO3
DU145 Mn\5R5l1d3SxeHnjJGF{e2G7 NIDFbXk2KGR? NV7BO4xzTE2VTx?= NVW3SHlnUUN3ME20Nk4yPyEQvF2= Ml;sNlA1PjZ3NUW=
MIAPaCa2 MUTDfZRwfG:6aXOgRZN{[Xl? M13wPFUh\A>? MoTuSG1UVw>? MVzJR|UxRTVyLk[yJO69VQ>? MnTvNlA1PjZ3NUW=
PANC1 M2DQO2N6fG:2b4jpZ{BCe3OjeR?= MYK1JIQ> M1nkRmROW09? MnX6TWM2OD12MD60NkDPxE1? NUfyXI1NOjB2Nk[1OVU>
PC9 M1T5dmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2DhUmFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgSWdHWi2mZX\pZ4lmdnRiaIXtZY4hWEN7IHPlcIx{KHerdHigSWM2OCCxZjCwMlAyPyEQvF2= M3LEW|IyOjB6OECy
PC9 MnvDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NEj1XWZCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIdzd3e2aD3y[ZNqe3SjboSgbJVu[W5iUFO5JINmdGy|IHX4dJJme3OrbnegSWdHWiCHN{S2Y2E4PTBxVEe5NG0hdXW2YX70JJdqfGhiRVO1NEBw\iB5IN88US=> NXvK[404OjF{MEi4NFI>
PC3 NU[zU|hyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHHEO3AyOCEQvF2= M4X6WVczKGh? NYPXToc2TE2VTx?= NYDkNmNnUUN3ME23MlQh|ryP MUCyNVM2OzV2Nh?=
MDA-MB-468 NH;2WWdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVH0clNMOTByIN88US=> Mnr6OFghcA>? Mm\CSG1UVw>? MWDBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eR?= NVXlR|hMOjF2Mkm2N|I>
Plasmodium falciparum NX3YRpRZeUiWUzDwdo9ncWyrbneg[o9zKGmwaHnibZRwenNib3[gVIxie22xZHn1cUBn[WylaYDhdpVuKHC{b3zp[oVz[XSrb36= MUOyNVgyPzB2NR?=
NCI-H1993 MnPHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVPnfJJCPzJiaB?= M2rPXGROW09? Mm\pTWM2OD1yLkGg{txO MnjYNlE6OTZ2M{O=
NCI-H292 M1PqcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2izTVczKGh? MVHEUXNQ MlvyTWM2OD1yLkCyJO69VQ>? M{\CXFIyQTF4NEOz
A431 MlnoT4lv[XOnIFHzd4F6 NXHETXBSOiCq MmLMSG1UVw>? MYnJcohq[mm2aX;uJI9nKEWJRmKgdIhwe3Cqb4L5cIF1cW:wIHnuJGVITi2|dHnteYxifGWmIHj1cYFvKEF2M{Gge4l1cCCLQ{WwJI9nKDBwMECxJO69VQ>? NIHKcVgzOjFyMUGzNi=>
MCF7 MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHPTXlgyODEEoN88[{9uVA>? M3rnSFQ5KGh? MkTTSG1UVw>? NXGzcHV5SW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDNR2Y4KGOnbHzzJI93\XKneIDy[ZN{cW6pIFXHSnIh\2WwZTD3bZRpKEmFNUCgc4YhOTJwMEWg{txO MWmyNlEyQTF|MB?=
BT474 MmTSR5l1d3SxeHnjJGF{e2G7 MVmxNEDPxE1? NX3yW5MzPDhiaB?= NEH3PVVEgXSxdH;4bYNqfHliYXfhbY5{fCC|ZYL1cU1{fGG{dnXkJIh2dWGwIFLUOFc1KGOnbHzz MUCyNlE{QDNyOB?=
MCF7 NXvvemZTS3m2b4TvfIlkKEG|c3H5 M4\Wc|ExKM7:TR?= M3XyUlQ5KGh? MnLCR5l1d3SxeHnjbZR6KGGpYXnud5Qhe2W{dX2td5Rien[nZDDoeY1idiCPQ1[3JINmdGy|IH;2[ZIu\XiycnXzd4lv\yCHcnLCNkBk\Wyucx?= NYLxXnpFOjJzM{izNFg>
HCC827 NVO5WpY{U2mwYYPlJGF{e2G7 M{ezUVAvOTJ3IN88US=> MorXNlQhcA>? M1XZTWROW09? NUHNbmRNUW6qaXLpeIlwdiCxZjDFS2ZTKGSnbDDFO|Q3NUF5NUCgcZV1[W62IGmxNFY5KGG3dH;wbI9{eGixconsZZRqd25? NVvvV2kxOjJ|M{mzOFI>
HCC827 M1jlZmtqdmG|ZTDBd5NigQ>? M{W0[VAvOTJ3IN88US=> NYHHS3NlOjRiaB?= MlHwSG1UVw>? NGTWUYFKdmirYnn0bY9vKG:oIFXHSnIh\GWuIFW3OFYuSTd3MDDteZRidnRvbXXkbYF1\WRiRYLrJJBpd3OyaH;yfYxifGmxbh?= NF\ielEzOjN|OUO0Ni=>
HCC827 M3nmZ2tqdmG|ZTDBd5NigQ>? M3PRdFAvOTJ3IN88US=> MXKyOEBp MUTEUXNQ M{e4[GlvcGmkaYTpc44hd2ZiRVfGVkBl\WxiRUe0Ok1CPzVyIH31eIFvfC2vZXTpZZRm\CCDa4SgdIhwe3Cqb4L5cIF1cW:w M{\MV|IzOzN7M{Sy
A431 MkTwT4lv[XOnIFHzd4F6 NXzqdoE2OTByIN88US=> M1fUTVMxKG2rbh?= M2fyWGlvcGmkaYTpc44hd2ZiRVfGVkBl\XKrdnXkJIZzd21iaIXtZY4hSTR|MTDj[YxtKG2nbXLyZY5mKGG|c3Xzd4VlKGG|IHnubIljcXSrb36gc4YheG:ueT3HcJUuXHm{IIDoc5NxcG:{eXzheIlwdiC5aYToJGlEPTBib3[gNU4xQCEQvF2= MmOzNlI3QTh5OEK=
H460 NHnoOYhEgXSxdH;4bYMhSXO|YYm= MYq3NkBp NXL2dVFuUUN3ME21MlU6KM7:TR?= MlzmNlI4Ojd2NEm=
HT-29 Ml;HR5l1d3SxeHnjJGF{e2G7 NGToR5M4OiCq MULJR|UxRTNwM{[g{txO NWjJPGZtOjJ5Mke0OFk>
SGC7901 MXHDfZRwfG:6aXOgRZN{[Xl? NWDRNG83PzJiaB?= NHn4clVKSzVyPUGwMlI3KM7:TR?= M3PsXFIzPzJ5NES5
A498 Ml;TS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NEHwbZJCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFG0PVgh[2WubIOg[ZhxemW|c3nu[{BGT0[UIHHu[EBUWkNid3n0bEBKSzVyIH;mJFgvPiEQvF2= M17Ye|IzQDF6OES4
Calu3 NXnCWYVJS3m2b4TvfIlkKEG|c3H5 MUKxNEDPxGdxbVy= MmTyO|IhcA>? NWfHSpdWUUN3ME2xMlYh|ryP MkPKNlMyOTZzNki=
FADU MUHDfZRwfG:6aXOgRZN{[Xl? MUGxNEDPxGdxbVy= M1u4RlczKGh? MlrGTWM2OD1yLkC1JO69VQ>? M3LmfVI{OTF4MU[4
HCC827 NYntXoRlS3m2b4TvfIlkKEG|c3H5 MlKxNVAh|rypL33M NWOxPGpuPzJiaB?= MWDJR|UxRTBwMECxOUDPxE1? M1rWOVI{OTF4MU[4
PC9 MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2DtW|ExKM7:Zz;tUC=> MnzaO|IhcA>? Mn\CTWM2OD1yLkCwNVQh|ryP M322b|I{OTF4MU[4
Sf9 MXXLbY5ie2ViQYPzZZk> M3PCV|EhcA>? M4jVcWROW09? MmX0TY5pcWKrdHnvckBw\iCqdX3hckBIW1RvdHHn[4VlKEWJRmKgUFg{PFJibYX0ZY51KGW6cILld5Nm\CC5aYToJGlEPTBib3[gNE4xOTVizszN Mom4NlM3OTF4OUG=
16HBE14o- NFjPdFlEgXSxdH;4bYMhSXO|YYm= Ml32NVAh|ryP MnXaO|IhcA>? MWTEUXNQ NXu4[I1KS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hOT[KQlWxOI8uKGOnbHzzJIhiemKxcnnu[{B4cWymIIT5dIUhTUeIUjDhd5Nme3OnZDDhd{Boem:5dHigbY5pcWKrdHnvckB4cXSqIFnDOVAhd2ZiMUKuO|Eh|ryP MXSyN|Y3QDR2MR?=
NCI-H1975 M2LMSmN6fG:2b4jpZ{BCe3OjeR?= NYDkVpprOTBizszN M1LqSlczKGh? NWXGXmVWTE2VTx?= MXHDfZRwfG:6aXPpeJkh[WejaX7zeEBo\W[rdHnubYIuemW|aYP0ZY51KGi3bXHuJG5EUS2KMUm3OUBk\WyuczDoZZJjd3KrbnegSWdHWiCOOEW4Vk9VPzlyTTDkc5VjdGVibYX0ZY51KGG|c3Xzd4VlKGG|IHfyc5d1cCCrbnjpZol1cW:wIIfpeIghUUN3MDDv[kA3NjlzNzFOwG0> MUOyN|Y3QDR2MR?=
16HBE M13vXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NV23NHRmPzJiaB?= MWLEUXNQ NGf6R4lCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIEG2TGJGKGOnbHzzJIV5eHKnc4Ppcochf2muZDD0fZBmKEWJRmKge4l1cCCLQ{WwJI9nKDFwNkCxJO69VQ>? NUXHclB2OjN5OUKzNVg>
16HBE MVPGeY5kfGmxbjDBd5NigQ>? NYS4eGFpOTByIN88US=> MX2xOVAhdWmw MWDEUXNQ M1TrZWlv\HWldHnvckBw\iCwaYTybYMhd3irZHWgdJJw\HWldHnvckBqdiCqdX3hckAyPkiERTDj[YxteyCneIDy[ZN{cW6pIIfpcIQhfHmyZTDFS2ZT NGDkSFUzOzd7MkOxPC=>
A549 MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUC3NkBp MXnEUXNQ M1TXUWFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4Sge4lt\CC2eYDlJGVITlJxaz3SZZMh\GWyZX7k[Y51KGi3bXHuJGE2PDliY3XscJMhf2m2aDDJR|UxKG:oIESuOlI3KM7:TR?= NGPGR48zOzd7MkOxPC=>
SH-SY5Y Ml;qR5l1d3SxeHnjJGF{e2G7 NF;0WoY4OiCq NELZNFFKSzVyPUG4MlIyKM7:TR?= M1TMNFI{QDdzOUC5
LoVo MnzaT4lv[XOnIFHzd4F6 NXPLXpNROiBiaB?= NG\YO|VFVVOR M{HiOWlvcGmkaYTpc44hd2ZiRVfGVkBxcG:|cHjvdplt[XSrb36ge4l1cCCLQ{WwJI9nKDBwME[yJO69VQ>? NG[wXlczOzl|MEm5OC=>
PC9 M4n6ZmtqdmG|ZTDBd5NigQ>? MoT4NkBp Ml\rSG1UVw>? M1nBXGlvcGmkaYTpc44hd2ZiRVfGVkBmgG:wIEG5JIRmdGW2aX;uJIFkfGm4YYTpcochdXW2YX70JJBpd3OyaH;yfYxifGmxbjDpckBpfW2jbjDQR|kh[2WubIOge4l1cCCLQ{WwJI9nKDBwMEC4O{DPxE1? NHLDOWMzOzl|MEm5OC=>
HCC827 MoXzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYnZVoFEPzJiaB?= MnnBTWM2OD1yLkCxNkDPxE1? NG\pXmYzOzl5M{G2PC=>
A549 M4LyOmtqdmG|ZTDBd5NigQ>? M2HaOlEh|ryP NEG0SYIyKGh? M1jX[WROW09? MUPJcohq[mm2aX;uJI9nKEWJRmKgZZV1d3Cqb4PwbI9zgWyjdHnvckB4cXSqIFnDOVAhd2ZiMD6wN|k6KM7:TR?= MX2yN|k5QDN3NB?=
A549 MY\GeY5kfGmxbjDBd5NigQ>? MUexJO69VQ>? M1vYXlEhcA>? NVX3dGdETE2VTx?= NVKzVlh2S2WubIXsZZIhfXC2YXvl MnjKNlM6QDh|NUS=
HCC827 MnPjT4lv[XOnIFHzd4F6 MVKwMlUh|ryP NUTxRWNVOiCq M2Lzd2ROW09? Mnz0TY5pcWKrdHnvckBw\iCHR1\SJJBpd3OyaH;yfYxifGmxbjDpckBo\W[rdHnubYIuemW|aYP0ZY51KGi3bXHuJGhESzh{NzDj[Yxtew>? MmDrNlM6QTN|Mki=
HCC827 MmHpSpVv[3Srb36gRZN{[Xl? MmTINE42KM7:TR?= MUCyJIg> M4C2WmROW09? NHH5c|RKdmirYnn0bY9vKG:oIHOtUYV1KHCqb4PwbI9zgWyjdHnvckBqdiCpZX\peIlvcWJvcnXzbZN1[W62IHj1cYFvKEiFQ{iyO{Bk\Wyucx?= MXGyN|k6OzN{OB?=
HCC827 M2LSOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NH\jS3cyOCEQvF2= NIXrTY44OiCq MXXEUXNQ NYDYb|RZSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBo\W[rdHnubYIue2Wwc3n0bZZmKGi3bXHuJGhESzh{NzDj[YxteyCqYYLic5JqdmdiRVfGVkBGPzR4IITvJGE4PTBiZHXs[ZRqd25id3n0bEBKSzVyIH;mJFAvODB3OEGg{txO M{\zd|I1ODV|Nke0
A431 NFS3W2JMcW6jc3WgRZN{[Xl? Ml3TNVAxKM7:TR?= MoTSN|AhdWmw MljQTY5pcWKrdHnvckBw\iCHR1\SJIlvKHOqZXSgcYVu[nKjbnWgeoV{cWOuZYOge4l1cCCLQ{WwJI9nKDFwMTFOwG0> NF\RWnEzPDB7NESzNi=>
BCRP-MDCK2 NXnqdW96TnWwY4Tpc44hSXO|YYm= M3u0flEvQCEQvF2= Mmq5O|IhcA>? NHrIUlBFVVOR NWLOOWdTUW6lcnXhd4Uhd2ZicHzhd41iKG2nbXLyZY5mKGW6cILld5Nqd25ib3[gRmNTWCCneIDy[ZN{cW6pIILldI9zfGW{IHflcoUhT0[S MlHVNlQyQDR{MUO=
BCRP-MDCK2 MlLsSpVv[3Srb36gRZN{[Xl? M2DSNlEvQCEQvF2= MV:3NkBp NX7rWXhzTE2VTx?= MUDS[YR2[3Srb36gc4YheGyjc33hJI1mdWK{YX7lJIV5eHKnc4Ppc44hd2ZiQlPSVEBmgHC{ZYPzbY5oKHKncH;yeIVzKGenbnWgS2ZR MXWyOFE5PDJzMx?=
MDCK Mn3pR5l1d3SxeHnjJGF{e2G7 MXO3NkBp NWXOZmJlTE2VTx?= NWTMcll1T0l3ME2xMlQ2KM7:TR?= NWDQfmk4OjRzOESyNVM>
MDCK2 NEHlNVJHfW6ldHnvckBCe3OjeR?= NWDF[4R7OS56IN88US=> NGjwdHo4OiCq M2rwd2ROW09? MWnJcohq[mm2aX;uJI9nKGi3bXHuJGJEWlBiZYjwdoV{e2WmIHHzd4V{e2WmIHHzJGhw\WOqc4SgN|M{PDJiYXPjeY12dGG2aX;uJJdqfGhiSVO1NEBw\iB|LkG5JO69VQ>? NFSxTGozPDF6NEKxNy=>
A431 MmLiR5l1d3SxeHnjJGF{e2G7 NULkbFFqPzJiaB?= NFzC[YZFVVOR MUXDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDBOFMyKGOnbHzzJIV5eHKnc4PpcochTUeIUjD3bZRpKEmFNUCgc4YhOC53NTFOwG0> NWjFNWk1OjR2MUGxNlM>
Calu3 MnjaR5l1d3SxeHnjJGF{e2G7 M1K2N|czKGh? NHfzfpJFVVOR NILRZmxEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBE[Wy3MzDj[YxteyCneIDy[ZN{cW6pIFjFVlIhf2m2aDDJR|UxKG:oIECuPVkh|ryP MUiyOFQyOTF{Mx?=
KB M4jLV2tqdmG|ZTDBd5NigQ>? MVexNEDPxE1? NHfFWmQyKGh? MX;EUXNQ M2npPGlvcGmkaYTpc44hd2ZiRVfGMZN1cW23bHH0[YQh[XW2b4Doc5NxcG:{eXzheIlwdiCxZjDFS2ZTKHerdHigTWM2OCCxZjCwMlAzPSEQvF2= NVPkXWdYOjR2MUGxNlM>
BEAS2B MlzIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2DrcFUxKM7:TR?= M3XXR|czKGh? M17LRmROW09? MYTJR|UxRTF|Lkm0JO69VQ>? MkLmNlQ3ODd3OUG=
NCI-H1975 MkK0SpVv[3Srb36gRZN{[Xl? M1TOR|ExOCEQvF2= MlryNVUxKG2rbh?= M3;CTmROW09? MoDJTY5lfWO2aX;uJI9nKE6RIIDyc4R2[3Srb36gbY4hcHWvYX6gUmNKNUhzOUe1JINmdGy|IHjhdoJwemmwZzDFS2ZTKEx6NUjSM3Q4QTCPIH31eIFvfA>? NXmyempbOjR4MEe1PVE>
Hela NI\jUlBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mo\MNlQhcA>? MmLTSG1UVw>? MkWyTWM2OD1{Lk[3JO69VQ>? MoH0NlQ4OzF{OEG=
HepG2 M4HOU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFjXdlczPCCq MlTsSG1UVw>? NF[2ZW1KSzVyPU[uOFIh|ryP Mo\0NlQ4OzF{OEG=
Sf9 MmHST4lv[XOnIFHzd4F6 NYrZT5BQOTBibXnu MVTEUXNQ NVzxe2V7UW6qaXLpeIlwdiCxZjDheZRweGixc4Doc5J6dGG2aX;uJI9nKHKnY3;tZolv[W62IHjpd{11[WepZXSgSWdHWiBqYX3pco8h[WOrZDC2OFUuOTF6Njmg[ZhxemW|c3XkJJdqfGhiSVO1NEBw\iByLkCyJO69VQ>? NEiyOYgzPDd|MUK4NS=>
SW620 MVLDfZRwfG:6aXOgRZN{[Xl? MYm0PEBp M2Tpc2ROW09? Mn\oTWM2OD1{OD6yJO69VQ>? MmSxNlQ6ODB3OUS=
HCC827 NX3UOopETnWwY4Tpc44hSXO|YYm= MkTlNE42KM7:TR?= NI\IOoIzKGh? M2CxW2ROW09? MoH2[I9meyCwb4SgbY5pcWKrdDDjMW1mfCCjc4Pld5Nm\CCjczDpcohq[mm2aX;uJI9nKEGNVDDwbI9{eGixconsZZRqd25? M4LFc|I{QTl|M{K4
HCC827 NIDUPFVHfW6ldHnvckBCe3OjeR?= NVzDRY13OC53IN88US=> NGDsRZozKGh? MnHJSG1UVw>? Mo\3[I9meyCwb4SgbY5pcWKrdDDjMW1mfCCjc4Pld5Nm\CCjczDpcohq[mm2aX;uJI9nKHB2ND:0NkBxcG:|cHjvdplt[XSrb36= NIXFZmIzOzl7M{OyPC=>
HCC827 NYLVOlVNS3m2b4TvfIlkKEG|c3H5 NHG1W2MxNjVizszN M{D6N|czKGh? NYPQUXBWTE2VTx?= MkizbIF{KG6xIHP5eI91d3irY3n0fS=> M3KwSVI{QTl|M{K4
NCI-H1975 NHvGRppHfW6ldHnvckBCe3OjeR?= Mmm0NVAh|ryP M4XvdFghcA>? MUDEUXNQ M{fNT4Rw\XNibn;0JIlvcGmkaYTpJGVITlJiYYPz[ZN{\WRiYYOgdoVlfWO2aX;uJIlvKEWUSzDwbI9{eGixconsZZRqd25? NUjNUnBsOjNzMU[xOlg>
A431 MVLLbY5ie2ViQYPzZZk> NUGxeYVSOSEQvF2= MYixJIg> MVnEUXNQ M1PUfYhieyCwbzDpdpJmfmW{c3nicIUhcW6qaXLpeIlwdiCxZjDFS2ZTKGG3dH;wbI9{eGixconsZZRqd25? M4TKVlI1QTByNUm0
LNCaP MoX0SpVv[3Srb36gRZN{[Xl? MUSxNEDPxE1? M1jD[|JpKG:{IESgbC=> MYDEUXNQ M4\t[oRw\XNibn;0JIlvcGmkaYSgZZV1d3Cqb4PwbI9zgWyjdHnvckBw\iCrbX31co9xfXKrZnnl[EBndGGpLYTh[4dm\CCEbYigZZN{\XO|ZXSgZZMhcW6lb4Lwc5JifGmxbjDv[kBcOzKSXVHUVC=> Ml3VNVg3Pjd|MUK=
H1975 MlLUT4lv[XOnIFHzd4F6 MmHGNUDPxE1? NGrJRogzPCCq MmG4SG1UVw>? M1G4bYRw\XNibn;0JIlvcGmkaYSgSWdHWiCyaH;zdIhwenmuYYTpc44hcW5iaIXtZY4hUDF7N{WgZ4VtdHNiaHHyZo9zcW6pIFXHSnIhVDh3OGKvWFc6OE1ibYX0ZY51 MVuyOFYxPzV7MR?=
H1975 M{T5bWZ2dmO2aX;uJGF{e2G7 MnjWNUDPxE1? MmPtNlQhcA>? Mof6SG1UVw>? M1mxXIRw\XNibn;0JIlvcGmkaYSgSXJMKHCqb4PwbI9zgWyjdHnvckBqdiCqdX3hckBJOTl5NTDj[YxteyCqYYLic5JqdmdiRVfGVkBNQDV6Uj;UO|kxVQ>? NYXISJNWOjR4MEe1PVE>
HCC827 M{e0bWtqdmG|ZTDBd5NigQ>? NUC1fY1bOC5zMTFOwG0> MYCxJIg> MoDPSG1UVw>? NXTPRo5{cGG|IH7vJIlzemW4ZYLzbYJt\SCrbnjpZol1cW:wIH;mJGVITlJiYYPz[ZN{\WRiYYOgdoVkd3[ncomgc4YhTUeIUjDheZRweGixc4Doc5J6dGG2aX;u NEHLVHEzPDF{NEi5PC=>
H1975 MkDuT4lv[XOnIFHzd4F6 NETQcZUxNjN|IN88US=> M3nDN|IhcA>? NFvJfHFFVVOR M1PnVYRw\XNibn;0JIlvcGmkaYSgSWdHWiCOOEW4Vk9VPzlyTTDkc5VjdGVibYX0ZY51KGG|c3Xzd4VlKGG|IILl[JVkfGmxbjDpckBCU1RicHjvd5Bpd3K7bHH0bY9v M1W5eFI1OTJ2OEm4
H1975 NX\HZZRTU2mwYYPlJGF{e2G7 M3fneVAvOzNizszN NXSzR5BCOiCq M{\jPGROW09? Mmm0[I9meyCwb4SgbY5pcWKrdDDFS2ZTKEx6NUjSM3Q4QTCPIHTveYJt\SCvdYThcpQh[XO|ZYPz[YQh[XNicnXkeYN1cW:wIHnuJGVTUyCyaH;zdIhwenmuYYTpc44> MViyOFEzPDh7OB?=
H1975 MoizT4lv[XOnIFHzd4F6 M3K1clAvOzNizszN M{C3ZlIhcA>? M{HMUGROW09? M{PLVIRw\XNibn;0JIlvcGmkaYSgSWdHWiCOOEW4Vk9VPzlyTTDkc5VjdGVibYX0ZY51KHCqb4PwbI9zgWyjdHnvci=> NU[5emZJOjRzMkS4PVg>
H1975 NFXub4JMcW6jc3WgRZN{[Xl? NV;3eI5MOC5zMkWg{txO M3TIZ|I1KGh? M2DP[2ROW09? MYnkc4V{KG6xdDDpcohq[mm2IFXHSnIhVDh3OGKvWFc6OE1ibYX0ZY51KFlzME[4JIF2fG:yaH;zdIhwenmuYYTpc44> MmjjNlI{Ozl|NEK=
H1975 NXnQdndiU2mwYYPlJGF{e2G7 NWL4TFJuOC53IN88US=> MYSyOEBp M3i4WGROW09? NWnTXFBN\G:nczDuc5QhcW6qaXLpeEBGT0[UIFy4OVhTN1R5OUDNJI12fGGwdD3t[YRq[XSnZDDFdosheGixc4Doc5J6dGG2aX;u M4\4eFIzOzN7M{Sy
H1975 Mn;TT4lv[XOnIFHzd4F6 MnPyNE42KM7:TR?= NWK4Vm12OjRiaB?= NHXUUWZFVVOR MVnkc4V{KG6xdDDpcohq[mm2IFXHSnIhVDh3OGKvWFc6OE1ibYX0ZY51NW2nZHnheIVlKEGtdDDwbI9{eGixconsZZRqd25? M3HhdVIzOzN7M{Sy
MIAPaCa2 NXjFRoxTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M37y[FIvPSEQvF2= MonSO|IhcA>? Mo\GSG1UVw>? NEDqRYxp[XNibn:g[5Jwf3SqIHnubIljcXSrb36= MVqyNFQ3PjV3NR?=
MIAPaCa2 MV\DfZRwfG:6aXOgRZN{[Xl? NVfSfmxqOSEQvF2= NFrUeHkyOCCm NFO4VYtFVVOR MW\oZZMhdm9iY4n0c5RwgGmlaYT5JIF{e2W|c3XkJIF{KHO3cIDy[ZN{cW:wIH;mJINwdG:weTDmc5Ju[XSrb36= NU\OWJZvOjB2Nk[1OVU>
MIAPaCa2 NFrhNW9CeG:ydH;zbZMhSXO|YYm= MXKxNEDPxE1? NWPzemxKOjSqIH;yJFQ5KGh? MoTrSG1UVw>? NV3ZWJQ1\G:nczDuc5QhcW6mdXPlJIFxd3C2b4Ppdy=> M2D2UVIxPDZ4NUW1
MIAPaCa2 NYjSepZzSXCxcITvd4l{KEG|c3H5 MoTqNlAh|ryP M{nve|I1KGh? MVXEUXNQ NVT4UWZS\G:nczDuc5QhcW6mdXPlJIFxd3C2b4Ppd{Bie3Onc4Pl[EBieyClYYPwZZNmKDNiYXP0bZZifGmxbh?= M3jpTFIxPDZ4NUW1
EoL-1 NX6zNVNKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{jac2lEPTB;NT6xO{BvVQ>? MXXTRW5ITVJ?
NCI-H720 MknjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MkHOTWM2OD1{Nj65NkBvVQ>? NFjn[mNUSU6JRWK=
NCI-SNU-5 M{DxU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVrLeFh7UUN3ME2yPE4yQSCwTR?= NUTwcYM1W0GQR1XS
EW-3 NHXpVIpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MX7JR|UxRTR4LkC0JI5O Mln0V2FPT0WU
HCC2218 NYjFe3VZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NInNdYhKSzVyPUWwMlU6KG6P MXnTRW5ITVJ?
HuO-3N1 MmXHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVzJR|UxRTV4LkC5JI5O Ml7hV2FPT0WU
DB M3X6[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MonlTWM2OD14MD65OkBvVQ>? MkfyV2FPT0WU
HSC-4 MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NX3Md|dVUUN3ME22NU42OyCwTR?= MWnTRW5ITVJ?
DOK MmjCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MV3JR|UxRTl|Lk[yJI5O NH7FS4FUSU6JRWK=
H9 M4rPWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mn;oTWM2OD1zM{euNkBvVQ>? NELOXo1USU6JRWK=
NCI-H292 NXi5d3JTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3\u[WlEPTB;MU[yMlY3KG6P M1TTRnNCVkeHUh?=
HSC-2 M1TvOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlPrTWM2OD1zNkWuOVchdk1? M2L6fnNCVkeHUh?=
LU-65 NHLaeXJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NEnpVJpKSzVyPUG2Ok43OSCwTR?= NWTDeGhqW0GQR1XS
BV-173 NF\5ZndIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGDPOHZKSzVyPUG4Ok42PSCwTR?= M3j4S3NCVkeHUh?=
LB2241-RCC M1v6eWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXX3cmZkUUN3ME2xPVQvQTNibl2= MlfkV2FPT0WU
KG-1 NEfX[ndIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MUDJR|UxRTJyND6zOEBvVQ>? NVXWUVNlW0GQR1XS
CHL-1 MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEPwVplKSzVyPUKwPE42OSCwTR?= NG[yUotUSU6JRWK=
KYSE-140 NWLiU4xHT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NH3RXI1KSzVyPUKwPU46PiCwTR?= Mk\HV2FPT0WU
DU-145 MkDES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWDJR|UxRTJzOT6wOEBvVQ>? M175RXNCVkeHUh?=
EW-13 NUS2OHRrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MnT6TWM2OD1{MkWuNUBvVQ>? MWHTRW5ITVJ?
KYSE-450 NEC0b|VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1XNXWlEPTB;MkS3MlkzKG6P NFjCSYxUSU6JRWK=
CAL-72 MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NV31RWQ{UUN3ME2yOlgvPzNibl2= NEDEWFVUSU6JRWK=
MEG-01 NVvKVYtCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGPT[pFKSzVyPUK3Ok44PiCwTR?= M3;ud3NCVkeHUh?=
HCE-T MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4mxTmlEPTB;Mke5Mlc6KG6P MluwV2FPT0WU
NCI-SNU-1 MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MnO4TWM2OD1{OEOuN|Ihdk1? NHnlZ2VUSU6JRWK=
CAL-27 NHu0WHFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnXxTWM2OD1{OEmuNFghdk1? NYnXbGZYW0GQR1XS
BALL-1 NUfVT5ptT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUfJR|UxRTJ7Nz60NkBvVQ>? M1nTW3NCVkeHUh?=
SBC-1 NUK0OmxqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2XQN2lEPTB;M{C3Mlc6KG6P MV3TRW5ITVJ?
CAL-54 M{TucGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHf1eXVKSzVyPUOxNU4zOyCwTR?= NXW2N3U3W0GQR1XS
TI-73 NFPqSmpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M17F[mlEPTB;M{GyMlc2KG6P MX;TRW5ITVJ?
P12-ICHIKAWA NVf4bpkzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVnJR|UxRTN{OD6wOkBvVQ>? MkDiV2FPT0WU
ACHN M4Tafmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NE\BdZpKSzVyPUOzNU41KG6P NWTFZpJYW0GQR1XS
PC-14 MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NH3zRVNKSzVyPUOzN{41OSCwTR?= M2LQV3NCVkeHUh?=
HCC1806 MlvKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M331SmlEPTB;M{O3MlUyKG6P M4TpN3NCVkeHUh?=
SK-MEL-24 MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2XFSmlEPTB;M{O3Mlg4KG6P MVPTRW5ITVJ?
A4-Fuk NEex[|ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4e1[2lEPTB;M{WwMlAzKG6P NXvDNWNLW0GQR1XS
ECC10 NUexVWhqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NUDNbVFMUUN3ME2zOVIvQTZibl2= MmXOV2FPT0WU
KASUMI-1 M2raeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mm[xTWM2OD1|Nk[uO|Mhdk1? NY\OWpcyW0GQR1XS
CAL-33 MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEnKPHVKSzVyPUO3NE46KG6P M2L4[3NCVkeHUh?=
MDA-MB-175-VII NX;CRo06T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mmj3TWM2OD1|N{iuPFghdk1? MknvV2FPT0WU
NUGC-3 NW\0dYxKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXv1epJJUUN3ME20NFEvQDFibl2= MkfCV2FPT0WU
KY821 NH[0XoFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NF;UcXpKSzVyPUSwPE42PyCwTR?= NX;kXGhyW0GQR1XS
CTB-1 MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2rZb2lEPTB;NEK0MlQhdk1? Mn3ZV2FPT0WU
DoTc2-4510 MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1LYfWlEPTB;NESyMlEzKG6P MnzPV2FPT0WU
EFO-27 MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUTJR|UxRTR3ND63OEBvVQ>? MVXTRW5ITVJ?
BPH-1 NIW1d3JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3TzfWlEPTB;NEmxMlE3KG6P NFPIbZFUSU6JRWK=
KYSE-270 NFLiTJFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXHndXNlUUN3ME20PVgvPjVibl2= M2nYXHNCVkeHUh?=
HO-1-N-1 NG\YV4VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NX;6T3dTUUN3ME21NFkvOjVibl2= MlHsV2FPT0WU
SK-MEL-1 MoLKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M17SW2lEPTB;NUGwMlk6KG6P NXH1VGd1W0GQR1XS
MOLT-13 M3\ZWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4fVdWlEPTB;NUG0MlgzKG6P Mlr2V2FPT0WU
TK10 NHzEVI1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHjFfIxKSzVyPUWxOU4yOSCwTR?= MnzVV2FPT0WU
HN MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVfIPVFvUUN3ME21NVcvOzhibl2= NUS5OXNFW0GQR1XS
SCC-15 Mn75S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2r1NWlEPTB;NUK1MlY5KG6P M{TWfHNCVkeHUh?=
NCI-H358 MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MY\JR|UxRTV{Nz62OkBvVQ>? MVXTRW5ITVJ?
KYSE-180 MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{eySmlEPTB;NUOwMlYzKG6P M3qxeHNCVkeHUh?=
NCI-H82 MoHnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnXKTWM2OD13NECuOUBvVQ>? NYLaSm1KW0GQR1XS
NB7 MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4j1[GlEPTB;NUS2MlMzKG6P MXzTRW5ITVJ?
DSH1 NHTyXoZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NIrLXpRKSzVyPUW2Ok45QCCwTR?= NVnjdZZCW0GQR1XS
RS4-11 NEGxdIFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3;0dmlEPTB;NU[4MlU6KG6P NYLuUY8{W0GQR1XS
CAN MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWPJR|UxRTV6MD63OkBvVQ>? MXHTRW5ITVJ?
Ca9-22 NUixOndnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXXJR|UxRTV6OD62OEBvVQ>? MWnTRW5ITVJ?
CAL-39 NVf2UGd4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlX5TWM2OD13OU[uN{BvVQ>? NXfCcWQ6W0GQR1XS
NCI-H1623 M37Me2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mlv6TWM2OD13OUmuN|Yhdk1? MVjTRW5ITVJ?
FADU MoLyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MoHqTWM2OD14MESuOlkhdk1? NFHOOo9USU6JRWK=
NB69 M4nEO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2TpRWlEPTB;NkG0MlM2KG6P M{S0O3NCVkeHUh?=
Ramos-2G6-4C10 MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NV7QN2t1UUN3ME22NlEvPDZibl2= Mn\KV2FPT0WU
LB1047-RCC MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXXOZWR7UUN3ME22NlUvOjlibl2= NUm4PHV3W0GQR1XS
MV-4-11 MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4XyZWlEPTB;NkK3Mlchdk1? MYrTRW5ITVJ?
DBTRG-05MG NETHUplIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXzJR|UxRTZ|Mj6yPEBvVQ>? MoDoV2FPT0WU
ME-180 MoDsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWXJR|UxRTZ|Mj65JI5O NFq5TndUSU6JRWK=
NBsusSR NUXHeHJST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MX\JR|UxRTZ2Nj61NkBvVQ>? M{WyOnNCVkeHUh?=
COR-L105 NH;KOWJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFTMTpFKSzVyPU[2Nk42OyCwTR?= Ml7oV2FPT0WU
ETK-1 NGixXG1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXXJR|UxRTZ4Mj61PUBvVQ>? NGnmTmdUSU6JRWK=
L-363 NGLIUm5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mor3TWM2OD14N{GuPVQhdk1? MWrTRW5ITVJ?
LU-134-A NH;Oc4ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MU\JR|UxRTdzOT6wPUBvVQ>? MlTnV2FPT0WU
NCI-H1770 MnrCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmX4TWM2OD15MkKuOEBvVQ>? NGnPOolUSU6JRWK=
HAL-01 MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{XJPWlEPTB;N{O0MlcyKG6P NHjGcINUSU6JRWK=
COLO-684 MlXSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MkjFTWM2OD15NUOuNFEhdk1? MYnTRW5ITVJ?
TE-6 NXG4W3dxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NU\BeGlSUUN3ME23OlQvOzFibl2= M2PBSnNCVkeHUh?=
A431 MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGXVUpZKSzVyPUe4NE4xPCCwTR?= MnK0V2FPT0WU
LU-135 M37We2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHLH[5RKSzVyPUe4N{4xOyCwTR?= M3HrW3NCVkeHUh?=
EC-GI-10 MlGzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3fsRWlEPTB;N{i4MlUzKG6P MkXaV2FPT0WU
TE-12 NGD1NY9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYHJR|UxRTh{MT6xNUBvVQ>? NGKyV5RUSU6JRWK=
LoVo MkjDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mo[1TWM2OD16NUmuNFYhdk1? NFHz[3ZUSU6JRWK=
23132-87 M4HL[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3XiU2lEPTB;OE[0MlI5KG6P NH\4OYpUSU6JRWK=
AU565 MknoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVGyU3dGUUN3ME24OlkvPiCwTR?= NYTJU4hDW0GQR1XS
DEL NXi4R4l4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4noUWlEPTB;OEe3MlY2KG6P NH7INHJUSU6JRWK=
COR-L88 M{jQNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4fx[GlEPTB;OEiyMlI3KG6P NV7vbmxDW0GQR1XS
NCI-H2126 NFjOe3lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVPJR|UxRTh6Mj64N{BvVQ>? M3Pxb3NCVkeHUh?=
CAPAN-1 MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGLOdWtKSzVyPUi4N{4zQSCwTR?= M4izbnNCVkeHUh?=
BT-474 NUWyUYZ{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mk\vTWM2OD17M{iuNVQhdk1? NEXVflFUSU6JRWK=
BHY NGnEN|VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWTJR|UxRTl5NT60PEBvVQ>? MVnTRW5ITVJ?
HT-3 NV63ZlZtT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MoHTTWM2OD17OEKuOFEhdk1? MVLTRW5ITVJ?
SK-NEP-1 MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4rvVWlEPTB;OUi5MlQ1KG6P MXvTRW5ITVJ?
MS-1 NHm3PFJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWrJR|UxRTl7ND62PUBvVQ>? NVXpSXpCW0GQR1XS
DOHH-2 MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NF7pc4pKSzVyPUGuNFAxOjFizszN MmrRV2FPT0WU
NCI-H1304 M4qzfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NEKyNYVKSzVyPUGuNFE3PDNizszN NX7DTWJGW0GQR1XS
EM-2 NEizXlFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3zjUGlEPTB;MT6wN|AyPiEQvF2= MmK2V2FPT0WU
MHH-PREB-1 M{CzcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHq2ZpdKSzVyPUGuNFg1PTFizszN NW\iTmJHW0GQR1XS
KU-19-19 MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHz6cXFKSzVyPUGuNFg2PDFizszN M17vS3NCVkeHUh?=
NCI-H1648 NWnOeFNCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVLmS2p3UUN3ME2xMlExPjF4IN88US=> M1jtOnNCVkeHUh?=
MKN1 MkXzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYLJR|UxRTFwMkG5PFch|ryP MoDhV2FPT0WU
SNU-449 MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1HXSmlEPTB;MT6yNlIxQCEQvF2= MX\TRW5ITVJ?
OAW-42 MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGDFdZZKSzVyPUGuNlc5OjVizszN NInifmZUSU6JRWK=
769-P NE\zTXRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUTtNFE{UUN3ME2xMlI4QTF6IN88US=> NHnobpBUSU6JRWK=
SW1088 NHLjXIdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MU\JR|UxRTFwMkm2NFch|ryP Mm\lV2FPT0WU
GCIY M1Gyb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVjJR|UxRTFwM{CxN|Ih|ryP M2rWcnNCVkeHUh?=
CTV-1 NH3x[2JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{foN2lEPTB;MT6zNFgh|ryP M2eyfXNCVkeHUh?=
NCI-H1092 NUHxO5N[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlLwTWM2OD1zLkOwPFUh|ryP M2fsV3NCVkeHUh?=
NKM-1 M2XUcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnjvTWM2OD1zLkOyOVk4KM7:TR?= M2fTZXNCVkeHUh?=
NCI-H1650 NWW0V3lrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{TDbGlEPTB;MT6zN|Q5OiEQvF2= M{\UPHNCVkeHUh?=
SW954 M{\uTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NY\qXWdbUUN3ME2xMlM1ODR6IN88US=> NXHHSocxW0GQR1XS
SW48 NH;QNXBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1PNN2lEPTB;MT6zOlYyQCEQvF2= MoHqV2FPT0WU
SK-N-DZ MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3vqUmlEPTB;MT6zOlk1PyEQvF2= NEjiVY1USU6JRWK=
KMOE-2 MkL1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{XwTWlEPTB;MT6zPVgyPSEQvF2= NIrTNohUSU6JRWK=
NB5 MkTjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHjGWWxKSzVyPUGuOFA5QTRizszN MXTTRW5ITVJ?
CCRF-CEM M2f0T2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M{LZ[mlEPTB;MT60NVEyKM7:TR?= M{fibHNCVkeHUh?=
RH-1 NX;QUnJCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYrrVpliUUN3ME2xMlQyOTN4IN88US=> NV3Ge|l2W0GQR1XS
NCI-H526 Mn\kS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYjJR|UxRTFwNEO4NlYh|ryP NG\LcXRUSU6JRWK=
697 NVS1Z5RJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MkPVTWM2OD1zLkS0NVA1KM7:TR?= NG\jPHBUSU6JRWK=
J82 NUnie5h{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MWXJR|UxRTFwNEW3OlYh|ryP MV\TRW5ITVJ?
BE-13 NIDOVZRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVLDd3U1UUN3ME2xMlUxPjdzIN88US=> NGjCS5lUSU6JRWK=
SAS NXTQcZVTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYHBSINiUUN3ME2xMlUyPjJ{IN88US=> NWL0RmlWW0GQR1XS
SCC-25 MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkTmTWM2OD1zLkWyN|IzKM7:TR?= Ml3SV2FPT0WU
LAMA-84 MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHfzdYNKSzVyPUGuOVM5OTVizszN NV\wXGl5W0GQR1XS
HSC-3 Mn\IS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUjJR|UxRTFwNUSzPEDPxE1? NXyxc5NkW0GQR1XS
BT-549 NWewfJNET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mn7RTWM2OD1zLkW4O|Q4KM7:TR?= NF7PNGZUSU6JRWK=
ML-2 Ml;YS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXzJR|UxRTFwNkSwNlkh|ryP NYrCToFnW0GQR1XS
BB30-HNC NHPwRXFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MmHvTWM2OD1zLk[4PVczKM7:TR?= MWXTRW5ITVJ?
PANC-03-27 NXn0O5M1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NH7uOWFKSzVyPUGuO|AyOzlizszN NIH0XYdUSU6JRWK=
COLO-678 NIrobXZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVHJR|UxRTFwN{O0OFQh|ryP M3vpbHNCVkeHUh?=
NCI-H1666 NWn6c4RCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWrtR2U2UUN3ME2xMlc1PzB2IN88US=> MoPEV2FPT0WU
NCI-H209 MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXX2OnlpUUN3ME2xMlc4OjZ7IN88US=> M1fZPXNCVkeHUh?=
EPLC-272H NYfQd2UzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MnT0TWM2OD1zLki1OVQ6KM7:TR?= NYnDdGFOW0GQR1XS
OMC-1 M{fVfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXLJR|UxRTFwOUm4PFgh|ryP MXvTRW5ITVJ?
HCC70 NXv4dZZoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Ml3LTWM2OD1{LkCwPFE2KM7:TR?= NIfjb3VUSU6JRWK=
CAL-12T NEXaRlFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MX;JR|UxRTJwMEG4OlEh|ryP NXfKUWhoW0GQR1XS
TGBC24TKB NFftOXNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2PLOGlEPTB;Mj6wNlk3OSEQvF2= M3PDNnNCVkeHUh?=
EKVX MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MX3JR|UxRTJwMES5N|kh|ryP NVu5OXdYW0GQR1XS
SW1116 MmLES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1XDUWlEPTB;Mj6wOlAxQSEQvF2= M1[2WXNCVkeHUh?=
NCI-H2009 Mmj5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVW3XIhKUUN3ME2yMlA3OjF2IN88US=> NGW0R4NUSU6JRWK=
RPMI-8866 M4DVTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXTJR|UxRTJwMEi0PFEh|ryP Mn33V2FPT0WU
KARPAS-45 MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXLJR|UxRTJwMUK0O|kh|ryP MnvyV2FPT0WU
RXF393 NF;vO4hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHHGOolKSzVyPUKuNVMxOzZizszN MVrTRW5ITVJ?
786-0 M3TDRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M37SeGlEPTB;Mj6xPFQxPiEQvF2= MX\TRW5ITVJ?
SCC-4 MoPCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnPhTWM2OD1{LkKxO|c3KM7:TR?= M3rVVXNCVkeHUh?=
BT-20 NIPl[3RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3PyfmlEPTB;Mj6yOlc1PCEQvF2= NHfiU2JUSU6JRWK=
A498 M2rsT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHn6TGtKSzVyPUKuNlk1OTVizszN M13zeHNCVkeHUh?=
IGROV-1 MmXXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NITieWdKSzVyPUKuN|EzOzdizszN M4fPSnNCVkeHUh?=
JVM-3 MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVLhN2ZzUUN3ME2yMlM1PjR|IN88US=> MlzqV2FPT0WU
NCI-H2170 M{Dsb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFvKVJlKSzVyPUKuN|Q4QDNizszN Mln4V2FPT0WU
EW-18 M{nScmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWX3UJBPUUN3ME2yMlM2PDdzIN88US=> NX7ISZU1W0GQR1XS
KU812 M1nLTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGrjU2pKSzVyPUKuN|Y4PzlizszN NFnoUYJUSU6JRWK=
NY MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{m0d2lEPTB;Mj6zO|I4KM7:TR?= MXnTRW5ITVJ?
HTC-C3 NW\QdGN1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NH7HdGhKSzVyPUKuOFIzPjdizszN NX7TRm9ZW0GQR1XS
CFPAC-1 NF7JTJJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4XvUGlEPTB;Mj60N|g3PCEQvF2= NGmz[odUSU6JRWK=
HH MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGnIO5RKSzVyPUKuOFk5PTRizszN M1XtWnNCVkeHUh?=
MKN7 MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWHmS4poUUN3ME2yMlYzPzR6IN88US=> MWTTRW5ITVJ?
TE-8 MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUDZSYdWUUN3ME2yMlY{PjV|IN88US=> NXrNepJlW0GQR1XS
MC-IXC MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4XJW2lEPTB;Mj62OFQ2OyEQvF2= M2DmSHNCVkeHUh?=
DMS-79 MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NE\nSXlKSzVyPUKuOlkzQDRizszN Ml33V2FPT0WU
Detroit562 NXG5SJNYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MX;JR|UxRTJwNkm4OFUh|ryP M2rnPXNCVkeHUh?=
HuP-T4 MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWnJR|UxRTJwN{K4NVgh|ryP NX\LdXVkW0GQR1XS
QIMR-WIL NXPadXI4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NEnVZZlKSzVyPUKuO|U6PTJizszN NG[3cnVUSU6JRWK=
BB65-RCC NHvIbVJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NWHhbmR3UUN3ME2yMlgxPzF|IN88US=> Mn7nV2FPT0WU
PC-3 NVjh[FVWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NI\NVFNKSzVyPUKuPFM{OTdizszN M3:wWnNCVkeHUh?=
OVCAR-3 NHGyU2ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXTJR|UxRTJwOEW1PVQh|ryP MmnjV2FPT0WU
KYSE-510 M4Tk[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWfacml3UUN3ME2yMlg3Pzh4IN88US=> M{H3THNCVkeHUh?=
HC-1 MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NI\ncFNKSzVyPUKuPVQxOTJizszN MYTTRW5ITVJ?
NCI-H1693 NFvUbXdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4frVGlEPTB;Mj65OVg6PyEQvF2= Mo[2V2FPT0WU
DU-4475 M{n0cmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYDJR|UxRTJwOUmwOVIh|ryP Mn\6V2FPT0WU
COLO-680N NWPOPWhOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{PYeGlEPTB;Mz6wNFQ6PSEQvF2= NYHhUlloW0GQR1XS
MN-60 NYq3e|R5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUXJR|UxRTNwMES5O|Qh|ryP NEPaOY1USU6JRWK=
BCPAP NWTleotiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGeySoVKSzVyPUOuNFgzQTVizszN M{foZnNCVkeHUh?=
647-V MkTxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3jkZ2lEPTB;Mz6xOlIzKM7:TR?= M3XBOnNCVkeHUh?=
HT-1376 MljHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYDJR|UxRTNwMkC1NFYh|ryP NVi4[lQ{W0GQR1XS
NCI-H1793 NVfzZlJ4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHjTZ3hKSzVyPUOuNlExQThizszN NVqxN5JSW0GQR1XS
SW1463 MmqyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFzINGRKSzVyPUOuNlYyQTJizszN NUPOTGlxW0GQR1XS
NCI-H727 NF70dGxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2TnN2lEPTB;Mz6zPFU5PCEQvF2= NGL3XlFUSU6JRWK=
LB771-HNC MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MmrMTWM2OD1|LkO5NVI3KM7:TR?= NGKxR4JUSU6JRWK=
D-542MG MmLaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXjGZ3oxUUN3ME2zMlQ1OjJ{IN88US=> MUPTRW5ITVJ?
NTERA-S-cl-D1 MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Ml\XTWM2OD1|LkS0PVU4KM7:TR?= NYLhWmpGW0GQR1XS
C8166 NHLDflRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M365T2lEPTB;Mz60OlUzOSEQvF2= M{XoW3NCVkeHUh?=
639-V NHjj[4tIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVvCWIRUUUN3ME2zMlU4Pzl{IN88US=> M2LWN3NCVkeHUh?=
TE-1 M2DFVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXvydIdTUUN3ME2zMlU6OTZ7IN88US=> MXXTRW5ITVJ?
OAW-28 MnvkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MoHHTWM2OD1|LkW5OFI3KM7:TR?= M3LLW3NCVkeHUh?=
SK-LU-1 MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1f6Z2lEPTB;Mz62NFY1PSEQvF2= M2X2eXNCVkeHUh?=
CaR-1 MnnRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUjmNo45UUN3ME2zMlYyODR6IN88US=> NGGzUoRUSU6JRWK=
A2780 MkT2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUnVTJVrUUN3ME2zMlY1ODh7IN88US=> MYnTRW5ITVJ?
C2BBe1 NUDxXY82T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHrzXldKSzVyPUOuOlQ1ODdizszN MXvTRW5ITVJ?
SK-MES-1 NFew[G9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2PydWlEPTB;Mz62OFYyPCEQvF2= NUi3NIp6W0GQR1XS
PANC-10-05 M2i5Z2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVTJR|UxRTNwN{KwO|Ih|ryP NHn2TFZUSU6JRWK=
J-RT3-T3-5 MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGOxZYVKSzVyPUOuO|U1ODZizszN NIf4cZdUSU6JRWK=
ES4 NXLx[ItVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmLXTWM2OD1|LkiyNlg3KM7:TR?= NFnBSWpUSU6JRWK=
NCI-H28 NH61dmRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3nQ[mlEPTB;Mz64Nlk3OSEQvF2= M4LHeHNCVkeHUh?=
NCI-H1155 Mme3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2Did2lEPTB;Mz64OFE2QSEQvF2= NGPIS4VUSU6JRWK=
KURAMOCHI MnvIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1zHNWlEPTB;Mz64OlA2PiEQvF2= MWTTRW5ITVJ?
NCI-H69 NWHiSm0yT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVTMfpFVUUN3ME2zMlkxOTd6IN88US=> NH74Um1USU6JRWK=
IST-MES1 M1u5NGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXzJR|UxRTNwOUSwNlkh|ryP MmSwV2FPT0WU
NH-12 M{SxOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MX;JR|UxRTNwOUSxPFch|ryP M{m5N3NCVkeHUh?=
JVM-2 MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWfEcmVPUUN3ME2zMlk1PzV{IN88US=> NUPSfZN3W0GQR1XS
EW-16 MnOwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{L1V2lEPTB;Mz65OVU4PyEQvF2= M2rUTHNCVkeHUh?=
NCI-H441 NXPHdHdrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NV7TVWU{UUN3ME2zMlk4ODF2IN88US=> NVHl[W1oW0GQR1XS
RCC10RGB MmHuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVHJR|UxRTRwMEGyOFYh|ryP MojIV2FPT0WU
TCCSUP NF[2UnpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NY\OTIpkUUN3ME20MlEyODVizszN NYrSNW44W0GQR1XS
HL-60 NFLwVHNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NWHwSld[UUN3ME20MlEzOjRzIN88US=> MUPTRW5ITVJ?
EW-11 MlHoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWLJR|UxRTRwMUOyOlEh|ryP NUPaV3lTW0GQR1XS
KARPAS-299 NUXNfYwxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGPJXJRKSzVyPUSuN|ExOTNizszN M1nkUnNCVkeHUh?=
SNU-C2B M3vxRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NUSwOXl3UUN3ME20MlM1Pjh4IN88US=> MUPTRW5ITVJ?
LU-139 NFPGbnlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXvJR|UxRTRwM{eyOFch|ryP M37QdHNCVkeHUh?=
HCC1937 MnHUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M13FTGlEPTB;ND6zO|k6OyEQvF2= MVfTRW5ITVJ?
GR-ST MkXuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2TYNmlEPTB;ND60N|E5KM7:TR?= MWTTRW5ITVJ?
SK-OV-3 NWq1fVJyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWHydXFLUUN3ME20MlQ3ODR{IN88US=> NH3XOZdUSU6JRWK=
A172 MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHS2bGdKSzVyPUSuOVU2OjFizszN NEm1WG5USU6JRWK=
NB10 NXm5eXZST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXHJR|UxRTRwNUm3PFEh|ryP M4LzVHNCVkeHUh?=
P30-OHK M3yx[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1zq[WlEPTB;ND64NVkzQSEQvF2= MkX4V2FPT0WU
KYSE-520 Mm\4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4[ycmlEPTB;ND64PFAyQCEQvF2= M1THcHNCVkeHUh?=
KNS-62 NH3jbnJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NF\PNWdKSzVyPUSuPVA5ODdizszN MkXKV2FPT0WU
ES1 NXz4SJJFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2DIfWlEPTB;ND65OlA{PSEQvF2= NV7PdoFUW0GQR1XS
KOSC-2 MnT5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUXJR|UxRTRwOUm5OVkh|ryP M{XZR3NCVkeHUh?=
TE-9 M4rIRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVHJR|UxRTVwMEG1NlUh|ryP NETRZ5NUSU6JRWK=
NCI-H1838 MnHBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWLJR|UxRTVwMEKwO|Yh|ryP NX\oRXM1W0GQR1XS
KP-N-YN MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVvnSYozUUN3ME21MlEzPTlzIN88US=> NYDPUGF5W0GQR1XS
ALL-PO MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYrJR|UxRTVwMkK1PFch|ryP NIfsS|JUSU6JRWK=
NOMO-1 NFrSVGRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFLm[25KSzVyPUWuNlMyPzZizszN NXu1SoxGW0GQR1XS
CGTH-W-1 MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NV3ZPWN1UUN3ME21MlM5PTh2IN88US=> Mnz4V2FPT0WU
ATN-1 Mn;zS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWDFU256UUN3ME21MlQyOTh2IN88US=> M{fFOHNCVkeHUh?=
AGS NXrTTFVbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXTQOZBkUUN3ME21MlQ6PjF6IN88US=> NVHJOnBLW0GQR1XS
SW13 NHrR[plIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NIi0RZZKSzVyPUWuOVMzPjVizszN M2nFRnNCVkeHUh?=
SW1990 MmHMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUDxOoZWUUN3ME21MlYzOjh3IN88US=> NYXlOlBLW0GQR1XS
BFTC-905 NYexcHdbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3Pi[GlEPTB;NT62OVg4QCEQvF2= M3vh[3NCVkeHUh?=
RMG-I NGPBe|dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1rFd2lEPTB;NT62OVk1OiEQvF2= NYW0XGFVW0GQR1XS
HD-MY-Z M2D0WWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3z5RmlEPTB;NT62PFU5OSEQvF2= NHK3flZUSU6JRWK=
HCC1187 M4XTcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnvXTWM2OD13LkexNFMzKM7:TR?= M2DGcXNCVkeHUh?=
HCC2998 MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUf3VWg{UUN3ME21MlcyQDd5IN88US=> NGDnTVBUSU6JRWK=
RT-112 NY\qd5pRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2PkfmlEPTB;NT65NFI1PSEQvF2= MlWyV2FPT0WU
CAKI-1 Mmm3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHj3UJFKSzVyPU[uNFA6QDVizszN Ml71V2FPT0WU
HDLM-2 M37ZT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mo\WTWM2OD14LkCxOFg6KM7:TR?= NWPTTJc5W0GQR1XS
TE-10 NVPMRWdZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYjxOmc3UUN3ME22MlA1QDN|IN88US=> NGL6Z|lUSU6JRWK=
KE-37 NGPMOFBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1zBbWlEPTB;Nj6wO|I2QCEQvF2= MY\TRW5ITVJ?
RCM-1 NYOwfI84T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYPJR|UxRTZwMEe3NVkh|ryP NG\zU4dUSU6JRWK=
Mewo NGjT[WdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlPDTWM2OD14LkGxOFg4KM7:TR?= NGnVeHVUSU6JRWK=
L-428 M3Tr[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NELrd|hKSzVyPU[uNVgxOzdizszN MWjTRW5ITVJ?
8-MG-BA MlfjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWPlRpBTUUN3ME22MlE6Ozd7IN88US=> NWLtd5l[W0GQR1XS
SK-MEL-28 M17BNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NV7LUpdrUUN3ME22MlIxQTZ5IN88US=> MX3TRW5ITVJ?
VA-ES-BJ Mn\SS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{D3cmlEPTB;Nj6zNFQ3OiEQvF2= NWPHTm11W0GQR1XS
CAL-120 MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2P4W2lEPTB;Nj60OVE3OiEQvF2= M4TyNHNCVkeHUh?=
GAMG MmmwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUDJR|UxRTZwNUC2NkDPxE1? NFrTPVNUSU6JRWK=
MSTO-221H MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M33WNWlEPTB;Nj61NVE4KM7:TR?= Mn3NV2FPT0WU
GCT M{L6N2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXG2WmpWUUN3ME22MlU{Ozh5IN88US=> NY\xV5BuW0GQR1XS
SH-4 MnKwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXPGb5YxUUN3ME22MlU5QDR2IN88US=> NY\l[mc5W0GQR1XS
Calu-3 NGfhVJFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlHSTWM2OD14Lk[1OVY5KM7:TR?= NI\5SHJUSU6JRWK=
SK-HEP-1 NW\pTXF[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3vORWlEPTB;Nj63NVc2OyEQvF2= NV\5fWs{W0GQR1XS
PFSK-1 NIqwOnNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlzJTWM2OD14LkezOFc5KM7:TR?= NUjt[GE1W0GQR1XS
NB12 MofHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUHJR|UxRTZwN{i0NFQh|ryP M1;rT3NCVkeHUh?=
A388 NILGT49Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3zRUmlEPTB;Nj64PVUzKM7:TR?= NFO1W2hUSU6JRWK=
KLE MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYDJR|UxRTZwOU[1NVYh|ryP MnTzV2FPT0WU
TE-11 M{nCVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYm2bIFXUUN3ME23MlA1QTZ5IN88US=> NXLZS|c4W0GQR1XS
NCI-H2405 MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2fwNmlEPTB;Nz6wPFM6OyEQvF2= NGLXVFlUSU6JRWK=
OVCAR-4 NEnocolIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MUjJR|UxRTdwMUWzOUDPxE1? MmjMV2FPT0WU
KP-N-YS NVL0e|RnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXzJR|UxRTdwMUixOEDPxE1? M3zIeHNCVkeHUh?=
NOS-1 MmjpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1LJcGlEPTB;Nz6yOVgzQCEQvF2= Mln6V2FPT0WU
DMS-114 MkDuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWPJR|UxRTdwMkm2N|Eh|ryP M3nvdnNCVkeHUh?=
NCI-H2030 NHu4TWtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYTJR|UxRTdwM{O2PVgh|ryP MYnTRW5ITVJ?
HEL MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHn4Z|FKSzVyPUeuN|c2OjFizszN NYHLVpR2W0GQR1XS
CAL-62 MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUfJR|UxRTdwM{m4OlYh|ryP MnP5V2FPT0WU
COLO-668 NWraZnNOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHT6blhKSzVyPUeuOFM6PjdizszN NUSweo1jW0GQR1XS
SKG-IIIa NU\aeXlRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmDXTWM2OD15LkS1N|gyKM7:TR?= M{TQWXNCVkeHUh?=
HCC1419 M4nLSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Ml3OTWM2OD15LkS2PFM{KM7:TR?= NVT0c3hEW0GQR1XS
OS-RC-2 Mlu3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4rL[2lEPTB;Nz60PVg6PCEQvF2= MVnTRW5ITVJ?
COLO-829 NVnXVlhiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MnSwTWM2OD15Lk[2OFY{KM7:TR?= NIrZZmZUSU6JRWK=
NB13 MnHmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MY\JR|UxRTdwOEK2Olch|ryP NH;YdoNUSU6JRWK=
DK-MG MoPiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2nKNWlEPTB;Nz64N|IxOSEQvF2= MVjTRW5ITVJ?
SHP-77 MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4PlWWlEPTB;Nz64OlY2OyEQvF2= NUPKdmpxW0GQR1XS
NCI-H661 MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3S3[WlEPTB;OD6wOVg3PyEQvF2= MoPMV2FPT0WU
AM-38 NEf2TmpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXnQdGF6UUN3ME24MlE3OjhizszN MWjTRW5ITVJ?
VM-CUB-1 MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NIrMN4VKSzVyPUiuNVcxOjlizszN NGPoTVlUSU6JRWK=
KYSE-70 M2[4d2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXPJR|UxRThwMUm3OlEh|ryP NUTqOoNXW0GQR1XS
5637 MmnaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NEH2TJpKSzVyPUiuN|ExPTVizszN MXnTRW5ITVJ?
TGBC11TKB NWLveYVWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVzIU5cyUUN3ME24MlQ3OTZ2IN88US=> M4\ZZ3NCVkeHUh?=
EGI-1 M2nYOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NEHjd5NKSzVyPUiuOlAxQDhizszN NWDzOGI5W0GQR1XS
D-392MG MojOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NH;zW4NKSzVyPUiuOlYzOTRizszN M1PFeXNCVkeHUh?=
A673 NHm5TG5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MmHHTWM2OD16Lk[3OlEyKM7:TR?= M{jHPXNCVkeHUh?=
COLO-792 MmGwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnnmTWM2OD16Lke0PVQ3KM7:TR?= M1Xnc3NCVkeHUh?=
NCI-H1792 MnvrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mn;uTWM2OD16Lki4PVA{KM7:TR?= Mn\PV2FPT0WU
LS-1034 M2S5NGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NV21eFR6UUN3ME24Mlk1PjV{IN88US=> MX7TRW5ITVJ?
D-566MG M3G1bWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlXyTWM2OD17LkCxPFEh|ryP NGmzdmlUSU6JRWK=
NCI-H226 M2[yOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4D2bWlEPTB;OT6wPUDPxE1? NXnCWnVZW0GQR1XS
ChaGo-K-1 M4fiTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NUjwbHBuUUN3ME25MlExPTd7IN88US=> MV;TRW5ITVJ?
NCI-H2228 NG[4c5VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVnHXWFnUUN3ME25MlEyODhzIN88US=> M1\BenNCVkeHUh?=
RPMI-8226 NGT6WWNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MUHJR|UxRTlwMUGzNFQh|ryP M1u1WHNCVkeHUh?=
BFTC-909 M{jvU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlnhTWM2OD17LkG4Nlk4KM7:TR?= NFrsfoFUSU6JRWK=
HPAF-II NWHRelhXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHvQbo9KSzVyPUmuNlI2OThizszN M3fibnNCVkeHUh?=
Capan-2 Mnq1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1L1S2lEPTB;OT60NFExQSEQvF2= MlzjV2FPT0WU
IA-LM MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUDJR|UxRTlwNEG5OlYh|ryP MVvTRW5ITVJ?
KP-4 M{LmVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXzJR|UxRTlwNEi4N|gh|ryP NE[wOVdUSU6JRWK=
A101D M13a[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUTJR|UxRTlwNUG3NVkh|ryP M4XvPHNCVkeHUh?=
EFO-21 NFfncGpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHrNSFZKSzVyPUmuOVg4OzVizszN MWrTRW5ITVJ?
C32 MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFPrbndKSzVyPUmuOlM{PCEQvF2= NHPWSlBUSU6JRWK=
SW837 NVjueYxqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MkHTTWM2OD17Lki0PFIh|ryP NF;IVHpUSU6JRWK=
OCI-AML2 MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2\QXWlEPTB;OT64Olk3KM7:TR?= MmrRV2FPT0WU
NCI-H1355 MoXvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1\5UGlEPTB;OT65OFA5QCEQvF2= NIrsWnlUSU6JRWK=
NCI-H2342 M3rRN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NF7MfoxKSzVyPUGwMlAyPTVizszN MYLTRW5ITVJ?
A204 Mny1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MknQTWM2OD1zMD6wOFY3KM7:TR?= NHf5[WRUSU6JRWK=
CAL-51 MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NED0PZFKSzVyPUGwMlA5PzdizszN NFPoUIJUSU6JRWK=
HCE-4 M4L5XGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFjUfopKSzVyPUGwMlEyOjJizszN MnvsV2FPT0WU
NCI-H810 NI\UV2dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NWfqN2VtUUN3ME2xNE4yPTl5IN88US=> NGrpbIFUSU6JRWK=
DJM-1 MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NH;rdJRKSzVyPUGwMlE4OzJizszN MVzTRW5ITVJ?
SK-UT-1 MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MX3JR|UxRTFyLkK1O|Qh|ryP M2[2NnNCVkeHUh?=
U031 MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2XWd2lEPTB;MUCuNlY5PiEQvF2= NGLPbItUSU6JRWK=
YH-13 MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MoLlTWM2OD1zMD6zNFU4KM7:TR?= NVq4WoJsW0GQR1XS
K5 MlfPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mki5TWM2OD1zMD6zN|k2KM7:TR?= MUnTRW5ITVJ?
HEC-1 MmD0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUDJR|UxRTFyLkSwPFEh|ryP MXLTRW5ITVJ?
A2058 MoK0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWjJR|UxRTFyLkW0PVEh|ryP M4TaZ3NCVkeHUh?=
SW962 MojlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVjMOGVGUUN3ME2xNE43OjB2IN88US=> NGfw[mlUSU6JRWK=
VMRC-RCZ MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mn3FTWM2OD1zMD62O|Q6KM7:TR?= NVPSbnl7W0GQR1XS
D-336MG NGPXd4xIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHzWcWJKSzVyPUGwMlcxODVizszN MmrjV2FPT0WU
LXF-289 M{LFUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NILZdlhKSzVyPUGwMlc6PjdizszN MoS5V2FPT0WU
SW900 NFn3em5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mn31TWM2OD1zMD64NlI5KM7:TR?= NHHBTXZUSU6JRWK=
K-562 Mnr1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUHJR|UxRTFyLkizPVUh|ryP MmPhV2FPT0WU
HCC38 MmnKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mo\pTWM2OD1zMD65O|E3KM7:TR?= MWjTRW5ITVJ?
SF-295 M1[wWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHPmOIhKSzVyPUGwMlk6ODJizszN M1jUcXNCVkeHUh?=
LB831-BLC MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYLLdHpWUUN3ME2xNU4zPTV4IN88US=> NIn6RVhUSU6JRWK=
FTC-133 NG\DNHFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYfJR|UxRTFzLkOwPFEh|ryP M1;JdnNCVkeHUh?=
HCC1954 M3Hxd2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MljCTWM2OD1zMT60N|Yh|ryP MXfTRW5ITVJ?
GOTO NXy5[lczT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NH7BfmpKSzVyPUGxMlUzODZizszN NWj0eWpUW0GQR1XS
LS-411N NX\TV3lTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MoKxTWM2OD1zMT62NVAyKM7:TR?= MmjrV2FPT0WU
RPMI-7951 MlzHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1HWc2lEPTB;MUGuOlM1QCEQvF2= NEfQbXVUSU6JRWK=
NCI-H1299 MnnDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlmyTWM2OD1zMT62OlQ4KM7:TR?= Mke4V2FPT0WU
MLMA M{HtWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYjQbFFNUUN3ME2xNU43QTl5IN88US=> NFHkd3FUSU6JRWK=
MMAC-SF M3;ifmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWjFNYl[UUN3ME2xNU44OjV{IN88US=> Mnr3V2FPT0WU
UM-UC-3 MkXrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFnxWpdKSzVyPUGxMlc1OjFizszN MlTpV2FPT0WU
SCC-9 MlH1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYO2fpRYUUN3ME2xNU45OTVzIN88US=> MlTuV2FPT0WU
HOS M4jWTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXvJR|UxRTFzLki2PFMh|ryP MV;TRW5ITVJ?
OE19 Mki2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MV\JR|UxRTFzLkmzOlch|ryP M1;HdHNCVkeHUh?=
Mo-T NUPZV|NET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGDhSVlKSzVyPUGxMlk2PDFizszN M4LBbXNCVkeHUh?=
CAMA-1 NUDtWHEzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVrJR|UxRTF{LkG2N|Mh|ryP NV7NeGZMW0GQR1XS
U-118-MG NYTrcGtKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NF3VTJdKSzVyPUGyMlI1PDFizszN NY\GVohtW0GQR1XS
KS-1 M4\PW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NX3yO4YyUUN3ME2xNk4zQDN{IN88US=> M1PTXXNCVkeHUh?=
JAR MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkP3TWM2OD1zMj6zN|Y6KM7:TR?= MmPNV2FPT0WU
ABC-1 NUezVoJpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXPJR|UxRTF{LkO0NUDPxE1? M1z0cHNCVkeHUh?=
Daoy NVzMeWJoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MkX2TWM2OD1zMj60OVQzKM7:TR?= MoPSV2FPT0WU
C3A NXK4WJJvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{LrVmlEPTB;MUKuOVc5PSEQvF2= MXXTRW5ITVJ?
GT3TKB NWTCdHBTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4i2[mlEPTB;MUKuOlMzPyEQvF2= MW\TRW5ITVJ?
DMS-273 NX7wPZgxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVvJR|UxRTF{Lki2N|Mh|ryP NHjqbmhUSU6JRWK=
G-361 MmnjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVLJR|UxRTF{LkmxNlkh|ryP MVLTRW5ITVJ?
RH-18 MnHPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYTaWJhiUUN3ME2xN{4zQTZ{IN88US=> MXvTRW5ITVJ?
SN12C MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYXoVG94UUN3ME2xN{4{QDB6IN88US=> NIn0NmFUSU6JRWK=
NCI-H1993 MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4fPU2lEPTB;MUOuOFI5PSEQvF2= MlfTV2FPT0WU
LOXIMVI NXfEb|FHT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MnW5TWM2OD1zMz62NVUyKM7:TR?= MlmxV2FPT0WU
SK-PN-DW M33ONmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NV\3TpdsUUN3ME2xN{45PDJ5IN88US=> M4HhSnNCVkeHUh?=
KALS-1 MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1j5eGlEPTB;MUOuPFUzPSEQvF2= MkXVV2FPT0WU
LAN-6 M1iwVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWnJR|UxRTF2LkK1N{DPxE1? MXfTRW5ITVJ?
A549 M4O5ZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFzEOJZKSzVyPUG0MlQ4OTJizszN NWW3[nF3W0GQR1XS
RD NWHURZpuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MnzDTWM2OD1zND60PFE{KM7:TR?= MXfTRW5ITVJ?
TGBC1TKB NWHYNmFtT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXPJR|UxRTF2Lk[2NVUh|ryP MV3TRW5ITVJ?
NCI-H630 NXS3fIVZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHHzXGRKSzVyPUG0Mlk1PjdizszN MlHLV2FPT0WU
MIA-PaCa-2 M1\GRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHHS[pZKSzVyPUG0Mlk3QSEQvF2= MV;TRW5ITVJ?
NCI-H1755 NF7XXoJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Ml\6TWM2OD1zND65PVU{KM7:TR?= NYGyVIVjW0GQR1XS
MOLT-4 NFTLcI5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXn4e4tDUUN3ME2xOU4xPDl5IN88US=> M4n2TXNCVkeHUh?=
CW-2 MlPoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVLJR|UxRTF3LkG0NlEh|ryP MV;TRW5ITVJ?
COLO-320-HSR NWDIVZZCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVPFUWlqUUN3ME2xOU42OzB5IN88US=> NHe4XoFUSU6JRWK=
UMC-11 MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1Txc2lEPTB;MUWuO|UzOyEQvF2= NUCxbWZ2W0GQR1XS
MCF7 MofzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVTFXZE5UUN3ME2xOU45OTR3IN88US=> NXvTXJlFW0GQR1XS
NCI-H23 NV;hfYJrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXPRUXhOUUN3ME2xOU45PDN6IN88US=> M4DpdnNCVkeHUh?=
HuCCT1 NGr1RWRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Ml;0TWM2OD1zNT64O|Qh|ryP MlHpV2FPT0WU
MPP-89 MnzTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHOxPHZKSzVyPUG1Mlk1OTdizszN Mn\TV2FPT0WU
HT55 NFvnU2VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MUDJR|UxRTF3Lkm0O|gh|ryP NVvpeYFoW0GQR1XS
no-11 NYHScGtVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MoHmTWM2OD1zNT65OlY{KM7:TR?= MmPyV2FPT0WU
GP5d NIXOblZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Ml31TWM2OD1zNj6yNVg4KM7:TR?= NETIOlRUSU6JRWK=
BHT-101 M{DDUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFH3ZWxKSzVyPUG2MlI1OzlizszN NF7GbYVUSU6JRWK=
M059J M2W0N2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1HBNWlEPTB;MU[uNlg1KM7:TR?= M4PocXNCVkeHUh?=
D-283MED Mk\tS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MV3JR|UxRTF4LkSyNFkh|ryP MWfTRW5ITVJ?
BEN M{PGVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWXJR|UxRTF4LkWxOVUh|ryP NFi1NnJUSU6JRWK=
LB373-MEL-D M3;UXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M33zZmlEPTB;MU[uO|I{OiEQvF2= MUnTRW5ITVJ?
MEL-HO MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2P2dWlEPTB;MU[uPFg2PCEQvF2= MUjTRW5ITVJ?
GI-ME-N MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFzSVW9KSzVyPUG2MlkxOzJizszN MX\TRW5ITVJ?
RKO NIjqd3pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUj2TGRNUUN3ME2xO{4xPzR6IN88US=> M{PORXNCVkeHUh?=
MZ2-MEL MmHmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlXwTWM2OD1zNz6xN|Mh|ryP MVvTRW5ITVJ?
NCI-H1573 NGPDR3pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXXmVZNFUUN3ME2xO{4zQDJ4IN88US=> MXzTRW5ITVJ?
NCI-H1581 M1;GdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NF3ve3lKSzVyPUG3MlQ1OTFizszN NHi0cY1USU6JRWK=
NCI-H747 MoTZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{j0T2lEPTB;MUeuOVI6PyEQvF2= NF;LW4xUSU6JRWK=
SW1783 MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3HHXWlEPTB;MUeuOlQyPSEQvF2= MXnTRW5ITVJ?
Calu-6 NGPHdlRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGTTZ4xKSzVyPUG3MlY4QDJizszN MoLrV2FPT0WU
SF268 M3zodmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIi3WGJKSzVyPUG3MlY6PjlizszN M1zTdHNCVkeHUh?=
ES8 NHv1ZmZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1;leWlEPTB;MUeuPFU6OyEQvF2= NX7IcFNNW0GQR1XS
KM-H2 NUfMVHVST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mn[3TWM2OD1zNz65OFEyKM7:TR?= NGD6RZZUSU6JRWK=
D-502MG NHTLWW9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2fsPGlEPTB;MUeuPVgxQCEQvF2= MUPTRW5ITVJ?
HLE NWPSd|BjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MnX5TWM2OD1zOD6zNVQ5KM7:TR?= MkTLV2FPT0WU
SW982 MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4PobWlEPTB;MUiuOFA4PSEQvF2= MUDTRW5ITVJ?
MDA-MB-361 MnG4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHnSO3hKSzVyPUG4MlU2QDhizszN NH;iU45USU6JRWK=
NCI-H1563 MkTOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{fEV2lEPTB;MUiuO|EzPCEQvF2= NYnmVoZpW0GQR1XS
MFE-280 NXjyU5FDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MkHqTWM2OD1zOD63Nlk{KM7:TR?= NUnHO2VRW0GQR1XS
U251 MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEHBcJFKSzVyPUG4Mlc{PDdizszN Ml:xV2FPT0WU
KNS-42 MoHzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mnm4TWM2OD1zOD64NFE2KM7:TR?= NHXxXGlUSU6JRWK=
U-266 M1;BdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWPHVZdqUUN3ME2xPE45PjR7IN88US=> NIXDdHlUSU6JRWK=
OVCAR-8 M1Xr[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NH;YSFFKSzVyPUG4MlkzPzZizszN M4H5TnNCVkeHUh?=
MFH-ino MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVXJR|UxRTF6Lkm2Olkh|ryP NUnndI1pW0GQR1XS
D-263MG NWjEUmU{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlzkTWM2OD1zOT6wNVczKM7:TR?= M2T6N3NCVkeHUh?=
NCI-H1437 NFv1dYdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4fJXWlEPTB;MUmuNFQ3PyEQvF2= NXzKVlNIW0GQR1XS
NCI-H1048 MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3rrZmlEPTB;MUmuNlMzPiEQvF2= NHrrV5VUSU6JRWK=
NCI-H446 M33rdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYe3U|JpUUN3ME2xPU4{PTh7IN88US=> NIPRNJlUSU6JRWK=
NCI-N87 MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWnJR|UxRTF7LkW5PVIh|ryP NVr5WZVPW0GQR1XS
WM-115 M1Hzb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFKxW2tKSzVyPUG5MlY4PzRizszN MXPTRW5ITVJ?
HuH-7 MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXXJR|UxRTF7Lke0NlEh|ryP Mn3EV2FPT0WU
NCI-H650 NILZR5NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NYHoWJFqUUN3ME2xPU44PTB6IN88US=> NV3yTFJGW0GQR1XS
TYK-nu M3PxWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NUO1NFNJUUN3ME2xPU45Ozd6IN88US=> MkTyV2FPT0WU
Becker NHH1eoVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MkTkTWM2OD1zOT64OVQ4KM7:TR?= MWLTRW5ITVJ?
BB49-HNC Mn\aS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MX3JR|UxRTF7LkmyJO69VQ>? M2[z[3NCVkeHUh?=
HGC-27 M33J[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWW1Tol[UUN3ME2yNE4yOzl2IN88US=> NHvLfZNUSU6JRWK=
SiHa Mn\BS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1vjbmlEPTB;MkCuN|cyOiEQvF2= MorZV2FPT0WU
LB2518-MEL MkLiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4DUXmlEPTB;MkCuN|c{QSEQvF2= M17GSnNCVkeHUh?=
TE-5 M2n1dGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mke0TWM2OD1{MD63OFgzKM7:TR?= M2fIOXNCVkeHUh?=
IST-SL1 MkmyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXnJR|UxRTJyLke4O|kh|ryP M2q3UXNCVkeHUh?=
A375 MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MnOzTWM2OD1{MT6wOVY4KM7:TR?= M3vtc3NCVkeHUh?=
MC116 NGjBRVFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHH5SGlKSzVyPUKxMlA4OjNizszN MorhV2FPT0WU
GI-1 MlPaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUTCUVd5UUN3ME2yNU4yPyEQvF2= NYXWcVl5W0GQR1XS
HOP-62 MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUfkPJFVUUN3ME2yNU4zPzh2IN88US=> M2DOW3NCVkeHUh?=
PA-1 NXPwdoNuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MX7JR|UxRTJzLkK3PFch|ryP MXLTRW5ITVJ?
HT NHz4SnZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NEjqUVRKSzVyPUKxMlQ{OzFizszN NWPrbZgxW0GQR1XS
HUTU-80 NFrUPZVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NIL1ZoZKSzVyPUKxMlQ{OzZizszN MVHTRW5ITVJ?
NCI-H1975 MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3GzWmlEPTB;MkGuOFYyKM7:TR?= MUHTRW5ITVJ?
GAK MoDuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYi1e|FqUUN3ME2yNU41QTlizszN NFeyPVNUSU6JRWK=
SK-N-AS NGLvPGVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVTXeYh3UUN3ME2yNU42PjF7IN88US=> MXnTRW5ITVJ?
OE33 M3O2XWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3W1XmlEPTB;MkGuOlA1PiEQvF2= NUnuTnpwW0GQR1XS
YKG-1 NVXoSGZuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MnnxTWM2OD1{MT62OVQ2KM7:TR?= NFvCPHdUSU6JRWK=
CAL-85 NW\rbpFpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmXOTWM2OD1{MT65N|A2KM7:TR?= MWXTRW5ITVJ?
NCI-H2347 MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4LMTmlEPTB;MkGuPVQzQCEQvF2= MkPGV2FPT0WU
PANC-08-13 MkjVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGHqT2lKSzVyPUKyMlAyOTlizszN Ml\xV2FPT0WU
SK-N-FI MlfiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYjJR|UxRTJ{LkOwO|Qh|ryP M1PaXnNCVkeHUh?=
NEC8 MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MlPBTWM2OD1{Mj61NFc5KM7:TR?= M3riXXNCVkeHUh?=
AN3-CA M37qWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVzB[WJPUUN3ME2yNk43ODh2IN88US=> NHTHeI9USU6JRWK=
HuO9 NXz1Wo1[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2jqc2lEPTB;MkKuO|M6PiEQvF2= NUjKSZgzW0GQR1XS
COLO-800 M3rqS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mmi4TWM2OD1{Mj63OlU{KM7:TR?= MV\TRW5ITVJ?
HT-29 Ml;jS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGLvOFVKSzVyPUKyMlg5OjNizszN MlnnV2FPT0WU
OC-314 NWTkNGVtT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NFjtRoxKSzVyPUKyMlg5PDVizszN M3Xnc3NCVkeHUh?=
G-401 NXq4c3NRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NEjPclNKSzVyPUKzMlA1PjJizszN M{PqfnNCVkeHUh?=
Saos-2 MmfYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlnLTWM2OD1{Mz61NVgzKM7:TR?= NG[0W2FUSU6JRWK=
UACC-62 Ml3vS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NY\VWHQ3UUN3ME2yN{42QDN|IN88US=> MY\TRW5ITVJ?
D-247MG NWHOflRmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NFr2NJNKSzVyPUKzMlc6OzlizszN MoTpV2FPT0WU
COLO-741 NGHxNVhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NIP0XG1KSzVyPUKzMlk2PjVizszN NEXac4NUSU6JRWK=
ES3 MmDqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVz5bHBiUUN3ME2yOE4xODJ|IN88US=> MkDaV2FPT0WU
LNCaP-Clone-FGC NHjqU|BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MV\JR|UxRTJ2LkCyNVEh|ryP MXPTRW5ITVJ?
SW1710 NFfkdZFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MoGwTWM2OD1{ND6xOVA3KM7:TR?= M1G5WHNCVkeHUh?=
LU-99A MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXLTZm5mUUN3ME2yOE4yQDRzIN88US=> NFXxepRUSU6JRWK=
HOP-92 MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NIjy[GdKSzVyPUK0MlczPSEQvF2= MnezV2FPT0WU
LS-123 MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkXsTWM2OD1{ND65OlE1KM7:TR?= NWPNO3hSW0GQR1XS
T84 Mlr1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXW3TYpQUUN3ME2yOE46PzZ3IN88US=> M2T5TXNCVkeHUh?=
HCT-116 NIDMN2ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlP0TWM2OD1{NT60NVg3KM7:TR?= NFPFPFJUSU6JRWK=
M14 NWS1cZpzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXXJR|UxRTJ3LkS0OFch|ryP M4js[3NCVkeHUh?=
OCUB-M M2[0T2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M{PwN2lEPTB;MkWuOFQ2PiEQvF2= NWP1O5FyW0GQR1XS
MKN45 NIm1dWNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NV7ndnhNUUN3ME2yOU43OzF3IN88US=> NEjuUo5USU6JRWK=
LCLC-97TM1 NYC3bHhLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXfJR|UxRTJ3LkeyPFUh|ryP Mm\rV2FPT0WU
RVH-421 M1[2T2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYDJR|UxRTJ3LkixOlEh|ryP NWm1SmM4W0GQR1XS
NKS-81-FD MnjpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NF;yTVlKSzVyPUK1MlkxOjFizszN NELrTpNUSU6JRWK=
NCI-H596 MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MlXLTWM2OD1{Nj6wOFg4KM7:TR?= M120SnNCVkeHUh?=
GB-1 MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MnPKTWM2OD1{Nj6xPFc6KM7:TR?= NWXvPI86W0GQR1XS
ZR-75-30 MnXhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlzwTWM2OD1{Nj6yNlk4KM7:TR?= NIrjW3FUSU6JRWK=
U-2-OS M2HWZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlGyTWM2OD1{Nj6zO|U4KM7:TR?= Mlz5V2FPT0WU
HuP-T3 M3zmemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYLaUJhZUUN3ME2yOk43OTB{IN88US=> M2q5c3NCVkeHUh?=
MOLT-16 MkHUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NX65e4x6UUN3ME2yOk43OTZ4IN88US=> MVTTRW5ITVJ?
U-87-MG MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEfaUYtKSzVyPUK2Mlc1OzhizszN M2DCRnNCVkeHUh?=
8505C MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NV[2Wo06UUN3ME2yOk46OTJ4IN88US=> NU[xUmhpW0GQR1XS
SK-MEL-3 NYjSSYNbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3m3PWlEPTB;Mk[uPVgzQCEQvF2= M2HW[3NCVkeHUh?=
COLO-824 Mnj2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MkKwTWM2OD1{Nz6yNVk2KM7:TR?= NGjpPXZUSU6JRWK=
EW-1 M1zzdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1S0UmlEPTB;MkeuN|U2PCEQvF2= MlnJV2FPT0WU
UACC-257 Mlf4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXjJR|UxRTJ5LkO4NFQh|ryP MoLuV2FPT0WU
Hs-578-T MmDPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmTmTWM2OD1{Nz61Nlk6KM7:TR?= NYHtWFhsW0GQR1XS
UACC-893 NF3yTWNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnS3TWM2OD1{Nz62OlMyKM7:TR?= NWXE[4lDW0GQR1XS
MHH-NB-11 MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{nNXWlEPTB;MkeuPFAxPyEQvF2= NX;KXnBmW0GQR1XS
KYSE-410 MkToS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUfN[5l2UUN3ME2yPE4zPzd7IN88US=> M4D6XHNCVkeHUh?=
SF126 NITaOFdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MoDxTWM2OD1{OD63OFM2KM7:TR?= M4DrbXNCVkeHUh?=
HT-144 NYLmcXJnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NE[3dIxKSzVyPUK5MlM{PjJizszN NWX2XVlyW0GQR1XS
SW1573 M1z5dGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIfhdpNKSzVyPUK5MlM2ODlizszN NEHSR5VUSU6JRWK=
SW620 MnjjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4DOWmlEPTB;MkmuN|Y1OSEQvF2= M{P5e3NCVkeHUh?=
SCH Mn:2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2nZcGlEPTB;MkmuPFg{OSEQvF2= NF;FN4FUSU6JRWK=
EW-22 NEfTdWxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUHXc2tVUUN3ME2zNE4yQTZ7IN88US=> M3H3OnNCVkeHUh?=
H4 MmrwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHPKSoRKSzVyPUOwMlQ3PTRizszN NEXSRZBUSU6JRWK=
CAS-1 MnLFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXHxUXp2UUN3ME2zNE44QDV7IN88US=> M{HQXHNCVkeHUh?=
MG-63 M3TTOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWHJR|UxRTNyLki0O|gh|ryP NYjUflRQW0GQR1XS
MDA-MB-415 MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4DJOmlEPTB;M{GuNVc2OyEQvF2= MmDtV2FPT0WU
NCI-H1395 M2K5cmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnzYTWM2OD1|MT6yN|I5KM7:TR?= NHfzRYFUSU6JRWK=
Ca-Ski NFy5eFRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFzUVZlKSzVyPUOxMlMyPzdizszN NXewSm44W0GQR1XS
BxPC-3 NXS1OoJQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3[3XGlEPTB;M{GuN|czQSEQvF2= M1K1RnNCVkeHUh?=
A3-KAW M374OGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1jzOGlEPTB;M{GuOFQ4OSEQvF2= MWDTRW5ITVJ?
T-24 NGf4ToxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGX6eJRKSzVyPUOxMlc{PjJizszN MoLWV2FPT0WU
NCI-H2029 M3ntZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1;t[WlEPTB;M{GuO|c3PSEQvF2= M1rqOHNCVkeHUh?=
YAPC MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{ixRWlEPTB;M{KuNFQxPyEQvF2= MVLTRW5ITVJ?
SK-MEL-2 NYH4U|hFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3X1TmlEPTB;M{KuNFUzKM7:TR?= M4PD[HNCVkeHUh?=
LS-513 M3HVN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIf3NG5KSzVyPUOyMlEyQDdizszN MXvTRW5ITVJ?
AsPC-1 NXj3OmJbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MkjwTWM2OD1|Mj6zOlA2KM7:TR?= NHfDR2hUSU6JRWK=
KYSE-150 MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVfJR|UxRTN{LkO3O|Mh|ryP M1LVcnNCVkeHUh?=
NCI-H520 NXvqbm93T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MWnJR|UxRTN{LkS0PFIh|ryP M1n2cnNCVkeHUh?=
JEG-3 NFPmeWNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlnZTWM2OD1|Mz6wPVcyKM7:TR?= NYX3bXU3W0GQR1XS
GMS-10 NHvaZplIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NI\DRW9KSzVyPUOzMlMxODRizszN NEfTTZFUSU6JRWK=
HT-1080 NG\vdoRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MojaTWM2OD1|Mz6zPUDPxE1? MlrtV2FPT0WU
NCI-H1651 M3fubmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MX;JR|UxRTN|LkO5OkDPxE1? Mo\aV2FPT0WU
NCI-H2122 NUjScWFnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmHCTWM2OD1|Mz61OVc1KM7:TR?= M4nPWHNCVkeHUh?=
ES5 M4XmVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NUPYUIZLUUN3ME2zN{44Ojl{IN88US=> Mm[0V2FPT0WU
8305C Ml31S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVLz[VM{UUN3ME2zN{46QTN5IN88US=> NWHqN41wW0GQR1XS
KM12 M3HoVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MY\JR|UxRTN2LkC0O|gh|ryP NG\YN3VUSU6JRWK=
HCT-15 MkfnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFTMcFhKSzVyPUO0MlEzPyEQvF2= MmCwV2FPT0WU
OVCAR-5 MmXJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnzQTWM2OD1|ND6yNVgzKM7:TR?= MYHTRW5ITVJ?
NCI-H2291 NY\ycJQ{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3nUbWlEPTB;M{SuNlQ4OiEQvF2= M2TVUHNCVkeHUh?=
CP50-MEL-B Mn71S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{\ac2lEPTB;M{SuOlU6OiEQvF2= MYHTRW5ITVJ?
C-33-A MnXNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGfvXnpKSzVyPUO0MlY5PTdizszN NYW3elA4W0GQR1XS
NCI-H2452 NGG5NoFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHviTppKSzVyPUO0Mlc5QDJizszN MXPTRW5ITVJ?
MDA-MB-157 NYDZdoFQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2f1XWlEPTB;M{SuPFE6OyEQvF2= MYTTRW5ITVJ?
LN-405 NVXXNWpDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHnXVIpKSzVyPUO1MlQ{ODhizszN MUjTRW5ITVJ?
MDA-MB-231 M2HndWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYfJR|UxRTN3LkWwOVQh|ryP NFLub2tUSU6JRWK=
EW-24 NGHBdHdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2[zU2lEPTB;M{WuOlM{PSEQvF2= NVnaeHlQW0GQR1XS
MKN28 Mkm3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlrFTWM2OD1|NT64NlM3KM7:TR?= NXX3PG5XW0GQR1XS
KINGS-1 M12wXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGTrbFJKSzVyPUO1Mlg1OzRizszN MVjTRW5ITVJ?
LC-2-ad NU\LbYNmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWX2OmZsUUN3ME2zOk43QTlizszN MkjZV2FPT0WU
IGR-1 NYS5No5sT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NUTOVmNMUUN3ME2zOk44ODd3IN88US=> MlywV2FPT0WU
SW626 M4LvbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2H3VGlEPTB;M{euNFQyPyEQvF2= NUjPN|RrW0GQR1XS
ONS-76 M3vGR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MoXkTWM2OD1|Nz6xN|A6KM7:TR?= NXXDbIN{W0GQR1XS
T98G NHP1T5VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXjJR|UxRTN5Lki2N|Uh|ryP M1PGSHNCVkeHUh?=
NB14 NHXZflFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NF36TIRKSzVyPUO4MlQ2PDRizszN NY[xXZFmW0GQR1XS
D-423MG NXr6[Zp7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NEG3WWRKSzVyPUO4MlQ5PjlizszN MXXTRW5ITVJ?
NCI-H510A MnnMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYnrW4dbUUN3ME2zPE43PDVzIN88US=> MVrTRW5ITVJ?
NMC-G1 NEP3[JhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGraZY9KSzVyPUO4MlczOjJizszN NYjSS45QW0GQR1XS
SW948 M4nQdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MW\JR|UxRTN6Lki5OFkh|ryP M1fXdnNCVkeHUh?=
MFM-223 MmXzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXPJR|UxRTN6Lkm0N|Eh|ryP MWTTRW5ITVJ?
PAN1 NUO5[5FST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MkfoTWM2OD1|OD65PVE6KM7:TR?= NWezcZVnW0GQR1XS
MZ7-mel NFLDZVBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2LJWmlEPTB;M{muNVE6QSEQvF2= NXLPVVdUW0GQR1XS
COLO-679 M4raPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIrDeZdKSzVyPUO5Mlk4ODhizszN M2TrO3NCVkeHUh?=
SW872 NIXTR|JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGrkdGxKSzVyPUSwMlIxOzFizszN Moi5V2FPT0WU
HT-1197 NYnaVWpJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Ml\ITWM2OD12MD6yPFY6KM7:TR?= M4\CS3NCVkeHUh?=
ES6 MnLFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUDJR|UxRTRyLkS1OVIh|ryP NYXLb5ZXW0GQR1XS
SNU-387 M1T0PWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGLHdGJKSzVyPUSwMlgzOzhizszN NYexfYZ3W0GQR1XS
T47D NG\yNZlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXPmRnZVUUN3ME20NU4xOTl{IN88US=> MUnTRW5ITVJ?
G-402 M1fJNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlX4TWM2OD12MT6wPFA6KM7:TR?= NXfM[|dRW0GQR1XS
MZ1-PC MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUHW[VBWUUN3ME20NU45OSEQvF2= MkjZV2FPT0WU
SW1417 M3PHNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MonnTWM2OD12Mj6zNFMh|ryP MorMV2FPT0WU
RERF-LC-MS MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVLJR|UxRTR{LkWwPFch|ryP NYLQeVZSW0GQR1XS
SF539 M1znOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYfJR|UxRTR{LkW1Nlkh|ryP M{nVcXNCVkeHUh?=
ESS-1 NYnvcHNDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHnrRoNKSzVyPUSzMlU2PThizszN NXLSUIZLW0GQR1XS
RO82-W-1 MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUjCPIdOUUN3ME20N{43OTV|IN88US=> NInLSYZUSU6JRWK=
S-117 NUXDfm5ZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYDSbZRKUUN3ME20N{43QTV6IN88US=> NGLLTINUSU6JRWK=
SW756 NHHt[G9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MkTETWM2OD12Mz64NlQzKM7:TR?= NWT4e4lQW0GQR1XS
CP66-MEL NFLpVIpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MorlTWM2OD12NT63NVQ{KM7:TR?= M4q0THNCVkeHUh?=
H-EMC-SS M{TFU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M{fvWWlEPTB;NEWuO|Y6OyEQvF2= M3jvbXNCVkeHUh?=
NCI-H2052 NFjLc|JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NI\LTYtKSzVyPUS1MlkxOjdizszN NHzvcpRUSU6JRWK=
SW684 MoW1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnzNTWM2OD12Nz6wNFgyKM7:TR?= NYC0WWQ2W0GQR1XS
HCC1569 NWjQd2lkT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUnJR|UxRTR5LkG2OVgh|ryP MnrqV2FPT0WU
KGN M3[0Nmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnTyTWM2OD12Nz6zN|EyKM7:TR?= NIL6dJJUSU6JRWK=
LCLC-103H MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MX3JR|UxRTR5LkS0NFQh|ryP NGrwZmdUSU6JRWK=
SW780 MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4fkVmlEPTB;NEeuOlM2OSEQvF2= MnuxV2FPT0WU
NCI-H1703 NGr6VmlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXjJR|UxRTR6LkOzOVIh|ryP NH65WYhUSU6JRWK=
HCC1395 MofhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3\Se2lEPTB;NEiuO|Q{OiEQvF2= M3;OfnNCVkeHUh?=

... Click to View More Cell Line Experimental Data

In vivo Gefitinib (100 mg/kg) improves the anti-tumor effect of radiotherapy in LoVo tumor xenografts. [3] Gefitinib treatment of nude mice bearing established human GEO colon cancer xenografts reveals a reversible dose-dependent inhibition of tumor growth because GEO tumors resumes the growth rate of controls at the end of the treatment. [4]

Protocol

Cell Research:[1]
+ Expand
  • Cell lines: NR6, NR6M and NR6W cells
  • Concentrations: 0-2 μM
  • Incubation Time: 72 hours
  • Method: Exponentially growing cells including NR6, NR6M, NR6M and NR6W cells are seeded in sextuple in 96-well plates at a concentration of 2000 cells/well, allowed to adhere and subsequently washed in PBS and incubated overnight in medium containing 0.5% FCS. Cells are then treated with varying concentrations (0-2 μM) of Gefitinib or the solute control DMSO and EGF. The optimal EGF concentration for inducing proliferation of NR6wtEGFR and NR6W cells has previously been determined and hence NR6wtEGFR and NR6W cells are supplemented with 10 nM and 0.1 nM EGF, respectively. EGF is not added to NR6 and NR6M cells. After 72 hours the amount of cells are measured by performing a MTT proliferation assay.
    (Only for Reference)
Animal Research:[3]
+ Expand
  • Animal Models: Female nude mice (cba nu/nu) aged 8–10 weeks are intra-dermal injected with LoVo cells.
  • Formulation: 0.5% polysorbate
  • Dosages: 100 mg/kg
  • Administration: Once daily by oral administration (0.1 mL/10 g body weight) for 14 days
    (Only for Reference)

Solubility (25°C)

In vitro DMSO 89 mg/mL (199.14 mM)
Ethanol 4 mg/mL (8.95 mM)
Water Insoluble
In vivo Add solvents individually and in order:
5% DMSO+corn oil
2.5mg/mL

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 446.90
Formula

C22H24ClFN4O3

CAS No. 184475-35-2
Storage powder
in solvent
Synonyms N/A

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT03050164 Completed Bioequivalence Study Hunan Kelun Pharmaceutical Co., Ltd. September 8, 2016 Phase 1
NCT02856893 Not yet recruiting NSCLC European Organisation for Research and Treatment of Cancer - EORTC|AstraZeneca March 2017 Phase 2
NCT02976116 Recruiting NSCLC Hutchison Medipharma Limited December 2016 Phase 2
NCT02951637 Not yet recruiting Lung Adenocarcinoma Shanghai Chest Hospital|Ruijin Hospital|Changhai Hospital December 2016 Phase 2
NCT02930954 Not yet recruiting Non-small-cell Lung Cancer Caicun Zhou|Tongji University November 2016 Phase 2
NCT02929693 Enrolling by invitation Cancer Shanghai University of Traditional Chinese Medicine|Shanghai Chest Hospital|Shanghai Pulmonary Hospital, Shanghai, China October 2016 Phase 3

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

EGFR Signaling Pathway Map

EGFR Inhibitors with Unique Features

Related EGFR Products

Tags: buy Gefitinib (ZD1839) | Gefitinib (ZD1839) supplier | purchase Gefitinib (ZD1839) | Gefitinib (ZD1839) cost | Gefitinib (ZD1839) manufacturer | order Gefitinib (ZD1839) | Gefitinib (ZD1839) distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID